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Guidelines for Using Release Notes 
Release Notes 4.4 provide modifications to the Specifications Manual for National Hospital 
Inpatient Quality Measures. The Release Notes are provided as a reference tool and are not 
intended to be used to program abstraction tools. Please refer to the Specifications Manual for 
National Hospital Inpatient Quality Measures for the complete and current technical 
specifications and abstraction information. 
 
The notes are organized to follow the order of the Table of Contents. The implementation 
date is 01-01-2015, unless otherwise specified. The headings are described below: 
 
•  Impacts - used to identify the impacted measures and portion(s) of the Manual Section. 
(i.e., Alphabetical Data Dictionary, Measure Information Form (MIF) and Flowchart 
(Algorithm)).  
•  Description of Changes - used to identify the section within the document where the 
change occurs, e.g., Definition, Data Collection Question, Allowable Values, and 
Denominator Statement - Data Elements.  
•  Rationale - provided for the change being made. 
 
Data elements that cross multiple measures and contain the same changes will be 
consolidated. 
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The notes in the tables below are organized to follow the Table of Contents in the 
specifications manual.  
 
 
Table of Contents 
Impacts: 
Section 2 Measurement Information 
Rationale:  These measures are being removed based on the FY 2014 IPPS Final Rule and at 
the direction of CMS. 
Description of Changes: 
2.1 Acute Myocardial Infarction (AMI) 
Remove: 
AMI-2 
AMI-10 
 
2.2 Heart Failure (HF) 
Remove: 
HF-1 
HF-3 
 
Impacts: 
Section 2 Measurement Information 
Rationale:  The PN-3a and PN-3b measures are being removed at the direction of CMS and 
based on the IPPS Fiscal Year 2014 Final Rule. 
Description of Changes: 
2.3 Pneumonia (PN) 
Measure Information Form (MIF) and Flowchart (Algorithm) 
Remove: 
PN-3a, PN-3b 
 
Impacts:   
Section 2 Measurement Information 
Rationale:  The Hospital IQR Program Measure, Surgery Patients with Perioperative 
Temperature Management, was removed in the IPPS Fiscal Year 2014 Final Rule. 
Description of Changes: 
2.4 Surgical Care Improvement Project (SCIP) 
Measure Information Form (MIF) and Flowchart (Algorithm) 
Remove: 
SCIP-Inf-10 
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Impacts: 
Section 2 Measurement Information 
Rationale:  The measure specifications for AMI-2, AMI-10, HF-3, and PN-3a have been 
removed from the Specifications Manual for National Hospital Inpatient Quality Measures and 
placed in the Specifications Manual for Joint Commission National Quality Core Measures. 
Description of Changes: 
Add at the bottom of last page of Table of Contents: 
Additional comments 
The measure specifications for AMI-2, AMI-10, HF-3, and PN-3a have been removed from the 
Specifications Manual for National Hospital Inpatient Quality Measures effective 01/01/2015, 
however, these will continue to be used by The Joint Commission and are available in the 
Specifications Manual for Joint Commission National Quality Core Measures which is located 
on The Joint Commission’s website at the following link: 
http://manual.jointcommission.org/bin/view/Manual. 
 
Impacts: 
10.5 CMS AMI Episode-of-Care Payment Measure 
Rationale:  The section name is being revised to reflect all payment measures.  In addition, a 
new payment measure is being added. 
Description of Changes: 
Change section name from: 
10.5 CMS AMI Episode-of-Care Payment Measure 
To 
10.5 CMS Payment Measures 
 
Add new measure: 
MSPB-1: Medicare Spending Per Beneficiary (MSPB) 
 
 
 
Acknowledgement 
No updates in this section. 
 
 
 
Introduction 
No updates in this section. 
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Using the Specifications Manual for National Hospital Inpatient Quality Measures 
Impacts: 
Not Applicable (N/A) 
Rationale:  The HF-1 measure is being removed based on the FY 2014 IPPS Final Rule and 
at the direction of CMS.  Example needs changed in Measurement Information sub-section. 
Description of Changes: 
Section 2 - Measurement Information 
Change third sentence in first paragraph to:  
For example, in the Stroke (STK) measure set, the measure that addresses STK patients 
receiving VTE prophylaxis is listed as: STK-1 and measure short name: Venous 
Thromboembolism (VTE) Prophylaxis. 
 
Impacts: 
N/A 
Rationale: This section is being updated to provide information on included measures.  
Description of Changes: 
Section 10 – CMS Outcome Measures (Claims Based) 
Change first sentence in first paragraph to: 
This section of the manual provides an overview and the Measure Information Forms for the 
CMS mortality, readmission and complication measures, as well as the AMI episode of care 
payment measure. 
Change second sentence in first paragraph to: 
In addition, this section provides a link to the development and technical specifications for the 
Agency for Healthcare Research and Quality (AHRQ) Claims-Based Quality Measures. 
Add second paragraph: 
The structural measures are listed in this section also, although they are not claim-based. Data 
entry for the structural measures is achieved through the secure side of QualityNet via an 
online tool available to authorized users.  
 
Impacts: 
N/A 
Rationale:  This change is to clarify for abstractors what measures in the specifications 
manual are considered chart-abstracted measures. 
Description of Changes: 
Section 2 - Measurement Information 
Add paragraphs: 
Measures listed in this section are known as Chart-Abstracted Measures. Chart abstraction is 
the review of medical record documentation from the current episode of care for purposes of 
data collection and submission. 
 
In addition, measures in this section which are eligible for voluntary electronic submission as 
eMeasures for the Hospital Inpatient Quality Reporting (IQR) program are identified in the 
specific Measure Information Form(s). 
Specifications Manual for Hospital Inpatient Quality Measures  Page 4 
Discharges 01-1-15 (1Q15) through 09-30-15 (3Q15) Release Notes Version 4.4 
Section 10 – CMS Outcome Measures (Claims Based) 
Add paragraph: 
The Inpatient Web-based Measure in this section is known as a Chart-Abstracted Measure as 
described in Section 2- Measurement Information. In addition, the measure is eligible for 
voluntary electronic submission as an eMeasure for the Hospital IQR program as identified in 
the specific Measure Information Form. 
 
 
SECTION 1 – Data Dictionary 
Introduction to Data Dictionary 
Impacts: 
General Abstraction Guidelines  
Rationale:  The verbiage used in the manual is being updated to reflect new guidance from 
the IPPS Final Rule. 
Description of Changes: 
Medical Record Documentation 
Change seventh paragraph to: 
Please note that hospitals that are selected for validation will need to provide a paper or 
electronic (i.e., CD, DVD, or thumb drive) copy of the current medical record in its entirety, 
including all previous testing or history documents used in abstraction. If a hospital uses 
electronic data for abstraction and is unable to provide a paper or electronic copy of these 
data, and the record is chosen for validation, there is the potential for a mismatch to occur. 
 
Alphabetical Data Dictionary  
Index Updates 
Impacts: 
Alphabetical Data Dictionary Index Rationale:  The current measure specifications exclude 
patients with cognitive impairment from all of the TOB and SUB measures, if there is 
documentation of cognitive impairment for the entire hospitalization. Since the alcohol use 
screen and/or tobacco use screen must be completed within 3 days after admission, cognitive 
impairment will now be evaluated in the Alcohol Use Status and Tobacco Use Status data 
elements, and the data element Cognitive Impairment will be removed from all of the TOB and 
SUB measures. 
Description of Changes: 
Alcohol Use Status  
Change under ‘Collected For’ column to: 
All SUB Measures 
Remove Cognitive Impairment row 
Tobacco Use Status 
Change under ‘Collected For’ column to: 
All TOB Measures 
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Impacts:   
Alphabetical Data Dictionary Index 
Rationale:  The Hospital IQR Program Measure, Surgery Patients with Perioperative 
Temperature Management, was removed in the IPPS Fiscal Year 2014 Final Rule. 
Description of Changes: 
Anesthesia End Date  
Anesthesia End Time 
Anesthesia Start Date 
Anesthesia Start Time 
Remove under ‘Collected For’ column: 
SCIP-Inf-10 
 
Impacts:   
Alphabetical Data Dictionary Index 
Rationale:  The Hospital IQR Program Measure, Surgery Patients with Perioperative 
Temperature Management, was removed in the IPPS Fiscal Year 2014 Final Rule. 
Description of Changes: 
Remove rows in their entirety: 
Anesthesia Type 
Intentional Hypothermia 
Temperature 
 
Impacts:  
Alphabetical Data Dictionary Index Antibiotic Administration Date 
Antibiotic Administration Route 
Antibiotic Administration Time 
Antibiotic Name 
Antibiotic Received 
Arrival Date 
Arrival Time 
Chest X-Ray 
Clinical Trial 
Comfort Measures Only 
Discharge Disposition 
ICU Admission or Transfer 
Pneumonia Diagnosis: ED/Direct Admit 
Transfer From Another Hospital or ASC 
Rationale:  The PN-3a and PN-3b measures are being removed at the direction of CMS and 
based on the IPPS Fiscal Year 2014 Final Rule. 
Description of Changes: 
Remove under ‘Collected For’ column: 
PN-3a  
PN-3b 
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Impacts:   
Alphabetical Data Dictionary Index Rationale:  These measures are being removed based on 
the FY 2014 IPPS Final Rule and at the direction of CMS. 
Description of Changes: 
Remove rows in their entirety: 
Aspirin Prescribed at Discharge 
Discharge Instructions Address Activity 
Discharge Instructions Address Diet 
Discharge Instructions Address Follow-up 
Discharge Instructions Address Medications 
Discharge Instructions Address Symptoms Worsening 
Discharge Instructions Address Weight Monitoring 
LDL-c Less Than 100 mg/dL 
Reason for No Aspirin at Discharge 
 
Remove under ‘Collected For’ column: 
AMI-2 
AMI-10 
HF-1 
HF-3 
Clinical Trial 
Comfort Measures Only 
Remove in the ‘Collected For’ column: 
All HF Measures 
Add in the ‘Collected For’ column: 
HF-2 
Clinical Trial 
Remove in the ‘Collected For’ column: 
AMI-1 
AMI-3 
AMI-5 
AMI-7 
AMI-7a 
AMI-8 
AMI-8a 
Add in the ‘Collected For’ column: 
All AMI Measures 
 
Impacts:   
Alphabetical Data Dictionary Index Rationale:  The PN-3a and PN-3b measures are being 
removed at the direction of CMS and based on the IPPS Fiscal Year 2014 Final Rule. 
Description of Changes: 
Remove under ‘Collected For’ column: 
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PN-3a  
PN-3b 
Remove rows in their entirety: 
Blood Culture Collected 
Initial Blood Culture Collection Date  
Initial Blood Culture Collection Time 
Impacts:   
Alphabetical Data Dictionary Index 
Element Name 
Reason for Discontinuation of Parenteral Therapy 
Rationale:  Clinical scenarios presented to the Technical Advisory Panel (TAP) justified the 
need for defined time frames, and the need for examples and clarifications to capture 
acceptable documentation for these data elements. 
Description of Changes: 
Change Element Name to: 
Reason for Discontinuation of Parenteral Anticoagulation Therapy 
 
Impacts:   
Alphabetical Data Dictionary Index Rationale:  This change is to adjust the measure flow logic 
and add a new data element that will exclude cases who received IV thrombolytic therapy in 3 
to 4.5 hours because a reason delayed initiation within 3 hours. 
Description of Changes: 
Add row under ‘Element Name’ and ‘Collected For’ column respectively: 
Reason for Extending the Initiation of IV Thrombolytic 
STK-4 
 
Impacts:   
Alphabetical Data Dictionary Index Rationale:  The Technical Advisory Panel reviewed clinical 
scenarios presented and determined that a timeframe was needed for documentation to be 
acceptable for these data elements. An additional data element was added to further define 
reasons for not providing prophylaxis to records in VTE-6 Hospital Acquired VTE. 
Description of Changes: 
Add row under ‘Element Name’ and ‘Collected For’ column respectively: 
Reason for No Administration of VTE Prophylaxis 
VTE-6 
 
 
Deleted Data Elements 
Impacts:   
Data Elements 
Rationale:  The Hospital IQR Program Measure, Surgery Patients with Perioperative 
Temperature Management, was removed in the IPPS Fiscal Year 2014 Final Rule. 
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Description of Changes: 
Remove in their entirety: 
Anesthesia Type 
Intentional Hypothermia 
Temperature 
 
Impacts:  
Data Elements 
Rationale:  These measures are being removed based on the FY 2014 IPPS Final Rule and at 
the direction of CMS. 
Description of Changes: 
Remove data elements in their entirety: 
Aspirin Prescribed at Discharge 
Discharge Instructions Address Activity 
Discharge Instructions Address Diet 
Discharge Instructions Address Follow up 
Discharge Instructions Address Medications 
Discharge Instructions Address Symptoms Worsening 
Discharge Instructions Address Weight Monitoring 
LDL c Less Than 100 mg/dL 
Reason for No Aspirin at Discharge 
 
 
Data Element Updates 
Impacts: 
ACEI Prescribed at Discharge 
ARB Prescribed at Discharge 
LVSD 
Reason for No ACEI and No ARB at Discharge 
Rationale:  These measures are being removed based on the FY 2014 IPPS Final Rule and at 
the direction of CMS. 
Description of Changes: 
Collected For 
Change to: 
The Joint Commission Only: AMI-3; CMS Voluntary Only: AMI-3 
 
Impacts: 
Admission Date 
Rationale:  The verbiage used in the manual for data elements collected for all records is 
being updated. 
Description of Changes: 
Notes for Abstraction 
Remove in second bullet, first sub-bullet: 
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(Form Locator 12) 
Remove in second bullet, second sub-bullet: 
in Form Locator 6 
ONLY ALLOWABLE SOURCES 
Change the third listing to: 
3.  UB-04 
Excluded Data Sources 
Change to: 
UB-04, “From” and “Through” dates 
 
Impacts: 
Alcohol Use Status 
Rationale:  The current measure specifications exclude patients with cognitive impairment 
from all of the TOB and SUB measures, if there is documentation of cognitive impairment for 
the entire hospitalization. Since the alcohol use screen and/or tobacco use screen must be 
completed within 3 days after admission, cognitive impairment will now be evaluated in the 
Alcohol Use Status and Tobacco Use Status data elements, and the data element Cognitive 
Impairment will be removed from all of the TOB and SUB measures. 
Description of Changes: 
Change: 
Collected For 
Change to: 
The Joint Commission Only:   All SUB Measures; CMS Informational Only:   All SUB 
Measures 
Allowable Values 
Add new value: 
7  The patient was not screened for alcohol use during the first three days of admission 
because of cognitve impairment. 
Notes for Abstraction 
Add new bullets and examples:   
•  Cognition refers to mental activities associated with thinking, learning, and memory. 
Cognitive impairment for the purposes of this measure set is related to documentation 
that the patient cannot be screened for alcohol use due to the impairment (e.g., 
comatose, obtunded, confused, memory loss) during the entire first three days of 
hospitalization. 
•  Cognitive impairment must be documented at all times during the first three days of the 
hospitalization in order to select value “7.”  If there is documentation in the medical 
record that a patient is cognitively impaired, and there is no additional documentation 
that the patient’s mental status was normal at any other time during the first three days 
of the hospitalization, i.e., alert and oriented the abstractor can select value “7.” 
•  If there is documentation that the patient has temporary cognitive impairment due to 
acute substance use (e.g., overdose or acute intoxication) value “7” cannot be selected. 
Examples of cognitive impairment include: 
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o  Altered Level of Consciousness (LOC) 
o  Altered Mental Status 
o  Cognitive impairment 
o  Cognitively impaired 
o  Confused 
o  Memory loss 
o  Mentally retarded 
o  Obtunded 
 
Impacts:  
Anesthesia End Date  
Anesthesia End Time 
Anesthesia Start Date 
Anesthesia Start Time 
Rationale:  The Hospital IQR Program Measure, Surgery Patients with Perioperative 
Temperature Management, was removed in the IPPS Fiscal Year 2014 Final Rule. 
Description of Changes: 
Anesthesia End Date 
Anesthesia End Time 
Anesthesia Start Time 
Remove under ‘Collected For’:  
CMS Voluntary Only: SCIP-Inf-10 
 
 
Anesthesia Start Date 
Remove under ‘CMS Voluntary Only’:  
SCIP-Inf-10 
Impacts: 
Antibiotic Administration Date 
Antibiotic Administration Route 
Antibiotic Administration Time 
Antibiotic Name 
Antibiotic Received 
Rationale:  The PN-3a and PN-3b measures are being removed at the direction of CMS and 
based on the IPPS Fiscal Year 2014 Final Rule. 
Description of Changes: 
Collected For 
Remove: 
CMS Voluntary Only: PN-3b 
 
Impacts: 
Arrival Date 
Arrival Time 
Clinical Trial 
Comfort Measures Only  
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Rationale:  The PN-3a and PN-3b measures are being removed at the direction of CMS and 
based on the IPPS Fiscal Year 2014 Final Rule. 
Description of Changes: 
Collected For 
Remove under ‘The Joint Commission Only’:  
PN-3a 
Remove under ‘CMS Voluntary Only’:   
PN-3a, PN-3b 
 
Impacts: 
Assessed for Rehabilitation Services 
Rationale:  This change is to clarify which providers should be considered members of the 
rehabilitation team. 
Description of Changes: 
Notes for Abstraction 
Change first bullet to: 
•  The assessment for rehabilitation services must be completed by a qualified provider. 
See the inclusion list. 
 
Suggested Data Sources 
Change to: 
PHYSICIAN/APN/PA/KT/PT/OT/SLT OR NEUROPSYCHOLOGIST DOCUMENTATION 
ONLY FOR REHABILITATION ASSESSMENT: 
•  Consultation notes 
•  Discharge summary 
•  History and physical 
•  Progress notes 
•  Referral forms 
•  Rehabilitation records 
•  Therapy notes (e.g., KT/PT/OT/SLT) 
 
Excluded Data Sources 
Add:   
Any documentation other than Physician/APN/PA/KT/PT/OT/SLT/Neuropsychologist 
 
Remove:  
•  Nursing assessments for activities of daily living (ADLs). 
•  Nursing notes 
 
Inclusion Guidelines for Abstraction 
Change second bullet to: 
•  Patient received rehabilitation services from a member of the rehabilitation team. 
 
Change third bullet with sub-bullets to: 
•  Members of the rehabilitation team: 
o  Advanced Practice Nurse (APN)  
Specifications Manual for Hospital Inpatient Quality Measures  Page 12 
Discharges 01-1-15 (1Q15) through 09-30-15 (3Q15) Release Notes Version 4.4 
o  Kinesiotherapist (KT) 
o  Neuro-psychologist (PsychD) 
o  Occupational therapist (OT) 
o  Physical therapist (PT) 
o  Physician  
o  Physician Assistant (PA) 
o  Speech and language pathologist (SLT) 
 
Impacts: 
Atrial Fibrillation/Flutter 
Rationale:  This change is to provide abstractor clarification for cases with questionable atrial 
fibrillation/flutter and/or conflicting documentation. 
Description of Changes: 
Definition 
Change to: 
Documentation by a physician/APN/PA that the patient has a history of ANY atrial fibrillation 
(e.g., remote, persistent, or paroxysmal) or atrial flutter OR a diagnosis or signed ECG tracing 
of ANY atrial fibrillation or flutter. 
 
Suggested Data Collection Question: 
Change to: 
Was there physician/APN/PA documentation of a diagnosis, signed ECG tracing, or a history 
of ANY atrial fibrillation/flutter in the medical record? 
 
Allowable Values: 
Change from: 
Y (Yes)  History of any atrial fibrillation/flutter or current finding of atrial 
fibrillation/flutter was documented. 
 
N (No)  History of any atrial fibrillation/flutter or current finding of atrial 
fibrillation/flutter was not documented, OR unable to determine from 
medical record documentation. 
To: 
Y (Yes)  There is physician/APN/PA documentation of a diagnosis or a history of 
ANY atrial fibrillation/flutter. 
 
N (No)  There is no physician/APN/PA documentation of a diagnosis or a history 
of ANY atrial fibrillation/flutter, OR unable to determine from medical 
record documentation. 
 
Notes for Abstraction 
Change to: 
•  If there is a documented history or diagnosis of ANY condition (e.g., remote, persistent, 
or paroxysmal) described in the definition statement, select “Yes”.  
•  If there is documentation of atrial fibrillation or flutter on a signed ECG, select “Yes.” 
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•  If there is a diagnosis of atrial fibrillation or flutter anywhere in the medical record, or 
documentation of a past history of atrial fibrillation or flutter anywhere in the medical 
record, select “Yes.”  
EXCEPTION: 
If there is conflicting documentation of atrial fibrillation or flutter during the 
hospitalization, the most current cardiologist documentation should be used.  If 
cardiology documentation is unavailable, the most current documentation by other 
physician/APN/PA should be used.  
•  If there is physician/APN/PA documentation of any of the following examples, disregard 
and continue to review the medical record for a confirmed diagnosis.   If no other 
documentation exists, select “No.” 
o  “suspected/suspicion of atrial fibrillation or flutter” 
o  “rule out atrial fibrillation/flutter” 
o  “questionable atrial fibrillation/flutter” 
o  “possible atrial fibrillation/flutter” 
•  If there is documentation of a history of an ablation procedure for atrial fibrillation/flutter, 
select “Yes.” 
•  If there is documentation of a history of atrial fibrillation or flutter that terminated within 8 
weeks following CABG, select “No.” 
•  If there is documentation of a history of transient and entirely reversible episode of atrial 
fibrillation or flutter due to thyrotoxicosis, select “No.” 
 
Suggested Data Sources 
Change to: 
Suggested Data Sources: PHYSICIAN/APN/PA DOCUMENTATION ONLY 
•  Discharge instruction sheet 
•  Discharge summary 
•  History and physical 
•  ECG report 
•  Holter monitor report 
•  Problem list 
•  Progress Notes 
•  Transfer sheet 
Inclusion Guidelines for Abstraction 
Change to: 
None 
Exclusion Guidelines for Abstraction 
Change to: 
•  PAC 
•  Paroxysmal atrial tachycardia 
•  Paroxysmal supraventricular tachycardia 
•  PAT 
•  Premature atrial contraction 
•  PST 
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Impacts: 
Birthdate 
Rationale:  The verbiage used in the manual for data elements collected for all records is 
being updated. 
Description of Changes: 
Suggested Data Sources 
Change last bullet to: 
•  UB-04 
 
Impacts: 
Blood Culture Collected 
Initial Blood Culture Collection Date 
Initial Blood Culture Collection Time 
Rationale:  The PN-3a and PN-3b measures are being removed at the direction of CMS and 
based on the IPPS Fiscal Year 2014 Final Rule. 
Description of Changes: 
Remove data elements in their entirety. 
 
Impacts: 
Chest X-Ray 
Pneumonia Diagnosis: ED/Direct Admit 
Rationale:  The PN-3a and PN-3b measures are being removed at the direction of CMS and 
based on the IPPS Fiscal Year 2014 Final Rule. 
 
Description of Changes: 
Collected For 
Remove under ‘The Joint Commission Only’:  
PN-3a 
Remove:   
CMS Voluntary Only: PN-3a, PN-3b 
 
Impacts: 
Clinical Trial 
Comfort Measures Only 
Discharge Disposition 
Rationale:  These measures are being removed based on the FY 2014 IPPS Final Rule and at 
the direction of CMS. 
Description of Changes: 
Collected For 
Remove under ‘The Joint Commission Only’: 
AMI-2, AMI-10, HF-3 
Remove under ‘CMS Voluntary Only’: 
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AMI-2, AMI-10, HF-1, HF-3 
 
 
Impacts: 
Cognitive Impairment 
Rationale:  The current measure specifications exclude patients with cognitive impairment 
from all of the TOB and SUB measures, if there is documentation of cognitive impairment for 
the entire hospitalization. Since the alcohol use screen and/or tobacco use screen must be 
completed within 3 days after admission, cognitive impairment will now be evaluated in the 
Alcohol Use Status and Tobacco Use Status data elements, and the data element Cognitive 
Impairment will be removed from all of the TOB and SUB measures.  
Description of Changes: 
Remove Cognitive Impairment data element in its entirety 
 
Impacts: 
Comfort Measures Only 
Rationale:  These changes will provide clarification to the abstractor and make the data 
element more consistent with the applicable measures.  
Description of Changes: 
Notes for Abstraction 
Change to: 
•  Only accept terms identified in the list of inclusions. No other terminology will be 
accepted.  
•  Physician/APN/PA documentation of comfort measures only (hospice, comfort care, etc.) 
mentioned in the following contexts suffices: 
o  Comfort measures only recommendation 
o  Order for consultation or evaluation by a hospice care service 
o  Patient or family request for comfort measures only 
o  Plan for comfort measures only 
o  Referral to hospice care service 
o  Discussion of comfort measures 
•  Determine the earliest day comfort measures only (CMO) was DOCUMENTED by the 
physician/APN/PA. If any of the inclusion terms are documented by the 
physician/APN/PA, select value “1,” “2,” or “3” accordingly.   
Example:  
“Discussed comfort care with family on arrival” noted in day 2 progress note – 
Select “2.” 
•   State Authorized Portable Orders (SAPOs):  
o  SAPOs are specialized forms or identifiers authorized by state law that translate a 
patient’s preferences about specific end-of-life treatment decisions into portable 
medical orders. 
Examples: 
  DNR-Comfort Care form 
  MOLST (Medical Orders for Life-Sustaining Treatment) 
  POLST (Physician Orders for Life-Sustaining Treatment) 
  Out-of-Hospital DNR (OOH DNR)  
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o  If there is a SAPO in the record that is dated and signed prior to arrival with an 
option in which an inclusion term is found that is checked, select value “1.” 
o  If a SAPO lists different options for CMO and any CMO option is checked, select 
value “1,” “2,” or “3” as applicable.  
o  If one or more dated SAPOs are included in the record (and signed by the 
physician/APN/PA), use only the most recent one.  Disregard undated SAPOs. 
o  For cases where there is a SAPO in the record with a CMO option selected:  If the 
SAPO is dated prior to arrival and there is documentation on the day of arrival or the 
day after arrival that the patient does not want CMO, and there is no other 
documentation regarding CMO found in the record, disregard the SAPO.  
Example: 
Patient has a POLST dated prior to arrival in his chart and ED physician states 
in current record “Patient is refusing comfort measures, wants to receive full 
treatment and be a full code.” 
•  Documentation of an inclusion term in the following situations should be disregarded. 
Continue to review the remaining physician/APN/PA documentation for acceptable 
inclusion terms.  If the ONLY documentation found is an inclusion term in the following 
situations, select value “4.” 
o  Documentation (other than SAPOs) that is dated prior to arrival or documentation 
which refers to the pre-arrival time period. 
Examples: 
  Comfort measures only order in previous hospitalization record. 
   “Pt. on hospice at home” in MD ED note. 
o  Inclusion term clearly described as negative or conditional.  
Examples: 
  “No comfort care" 
  "Not appropriate for hospice care" 
  “Comfort care would also be reasonable - defer decision for now” 
  “DNRCCA” (Do Not Resuscitate – Comfort Care Arrest) 
  “Family requests comfort measures only should the patient arrest.” 
o  Documentation of “CMO” should be disregarded if documentation makes clear it is 
not being used as an acronym for Comfort Measures Only (e.g., “hx dilated CMO” – 
Cardiomyopathy context). 
•  If there is physician/APN/PA documentation of an inclusion term in one source that 
indicates the patient is Comfort Measures Only, AND there is physician/APN/PA 
documentation of an inclusion term in another source that indicates the patient is NOT 
CMO, the source that indicates the patient is CMO would be used to select value “1,” “2,” 
or “3” for this data element.  
Examples:  
o  Physician documents in progress note on day 1 “The patient has refused Comfort 
Measures” AND then on day 2 the physician writes an order for a Hospice referral. 
Select value “2.” 
o  ED physician documents in a note on day of arrival “Patient states they want to be 
enrolled in Hospice” AND then on day 2 there is a physician progress note with 
documentation of “Patient is not a Hospice candidate.”  Select value “1.” 
 
Suggested Data Sources: 
Remove: 
IN THE FOLLOWING ONLY ACCEPTABLE SOURCES: 
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Add new first bullet: 
•  Consultation notes 
 
Add new fifth bullet: 
•  History and physical 
 
Inclusion Guidelines for Abstraction 
Add new bullet: 
Terminal extubation 
 
Impacts: 
Date Last Known Well 
Rationale:  This change is to clarify the abstraction guidelines for data elements that generate 
the majority of stroke abstraction questions and ease the burden of abstraction. 
Description of Changes: 
Suggested Data Collection Question 
Change to:  
What was the date associated with the time at which the patient was last known to be well or 
at his or her baseline state of health? 
 
Notes for Abstraction 
Change to:  
•  Enter the date associated with the Time Last Known Well. If the date last known 
well is unable to be determined from medical record documentation, enter “UTD.” 
•  The medical record must be abstracted as documented (taken at “face value”). When 
the date documented is obviously in error (not a valid date/format) and no other 
documentation is found that provides this information, the abstractor should select 
“UTD.”  
Example:  
Documentation indicates the Date Last Known Well was 03-42-20xx. No other 
documentation in the medical record provides a valid date. Since the Date Last 
Known Well is outside of the range listed in the Allowable Values for “Day,” it is 
not a valid date and the abstractor should select “UTD.” 
Note: Transmission of a case with an invalid date as described above will be rejected 
from the QIO Clinical Warehouse and the Joint Commission’s Data Warehouse. Use of 
“UTD” for Date Last Known Well allows the case to be accepted into the warehouse. 
•  If the date last known well is documented as a specific date and entered as Date Last 
Known Well on a “Code Stroke” form or stroke-specific electronic template, enter that 
date as the date last known well. Documentation of Date Last Known Well on a stroke-
specific form or template should be selected regardless of other dates last known well 
documented elsewhere in the medical record.   
•  References in relation to Arrival Date are acceptable (e.g., today, tonight, this evening, 
and this morning). The Date Last Known Well and the Arrival Date may be the same 
date or a different date.  
Examples:  
o  “Wife reports patient normal this evening until approximately 9 PM.” Hospital 
arrival is 0030 on 12-10-20xx.” Date Last Known Well is 12-09-20xx.  
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o  “Patient states he felt perfectly fine earlier today. At noon, he began to have 
trouble seeing.” Hospital arrival is 3:59 PM on 12-10-20xx.” Date Last Known 
Well is 12-10-20xx. 
•  If a reference to date last known well is documented without a specific date, enter that 
date for the Date Last Known Well.  If multiple dates are documented, select the 
earliest date.   
Examples: 
o  “Patient last known well today (day of arrival).”  Select Arrival Date for Date Last 
Known Well. 
o  “Patient normal yesterday (day before arrival) documented in H&P and consult 
note documents that patient was last known to be well on Monday (two days 
prior to arrival).”  Select Monday’s date for Date Last Known Well. 
 
Suggested Data Sources 
Add new bullet: 
•  Code Stroke form/template 
 
Inclusion Guidelines for Abstraction 
Change to: 
Signs and Symptoms of Stroke 
•  Sudden numbness or weakness of the face, arm or leg, especially on one side of the body 
•  Sudden confusion, trouble speaking or understanding 
•  Sudden trouble seeing in one or both eyes 
•  Sudden trouble walking, dizziness, loss of balance or coordination 
•  Sudden severe headache 
 
Impacts: 
Decision to Admit Date 
Decision to Admit Time 
Rationale:  These changes to the Notes for Abstraction and/or the Inclusion/Exclusion 
guidelines are being added for clarification in abstraction, based on questions received in the 
QualityNet Q&A tool. 
Description of Changes: 
Suggested Data Sources 
Remove: 
PHYSICIAN/APN/PA DOCUMENTATION ONLY 
 
Decision to Admit Date 
Inclusion Guidelines for Abstraction 
Change second bullet to: 
•  Disposition Date 
 
Impacts: 
Discharge Date 
Rationale:  The verbiage used in the manual for data elements collected for all records is 
being updated. 
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Description of Changes: 
Collected For 
Change to: 
CMS/The Joint Commission:  All Records  
Suggested Data Sources 
Change last bullet to: 
•  UB-04 
 
Impacts: 
Discharge Disposition 
Rationale:  The PN-3a and PN-3b measures are being removed at the direction of CMS and 
based on the IPPS Fiscal Year 2014 Final Rule. 
Description of Changes: 
Collected For 
Remove under ‘CMS Voluntary Only’:   
PN-3b 
 
Impacts: 
ED Departure Date 
Rationale:  These changes to the Notes for Abstraction and/or the Inclusion/Exclusion 
guidelines are being added for clarification in abstraction, based on questions received in the 
QualityNet Q&A tool. 
Description of Changes: 
Notes for Abstraction 
Remove fourth bullet: 
•  If there is documentation the patient left against medical advice and it cannot be 
determined what time the patient left against medical advice, select “UTD.” 
Exclusion Guidelines for Abstraction 
Change to: 
Patient Admission Date 
 
Impacts: 
ED Departure Time 
Rationale:  These changes to the Notes for Abstraction and/or the Inclusion/Exclusion 
guidelines are being added for clarification in abstraction, based on questions received in the 
QualityNet Q&A tool. 
Description of Changes: 
Notes for Abstraction 
Add new seventh bullet: 
•  Do not use documentation of vital signs or medications if they are later than the ED 
departure time. 
 
Exclusion Guidelines for Abstraction 
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Add second bullet: 
•  Patient Admission Time 
 
 
Impacts: 
Follow-Up Contact 
Rationale:  The current follow-up contact does not exclude patients who expire after discharge 
from TOB-4 and SUB-4.  Directions on the appropriate allowable value to select in order to 
exclude the case have been added. 
Description of Changes: 
Notes for Abstraction 
Add new fourth bullet: 
•  If follow-up contact was made and contact was made with a family member or other 
person who reports the patient expired within 30 days following discharge from the 
hospital, select allowable value “3.” 
 
Impacts: 
ICD-9-CM Other Diagnosis Codes  
Rationale: The verbiage used in the manual for data elements collected for all records is being 
updated. 
Description of Changes: 
Collected For 
Change to: 
CMS/The Joint Commission:  All Records  
Definition 
Change to: 
The other or secondary ICD-9-CM codes associated with the diagnosis for this hospitalization. 
Allowable Values 
Change from: 
Any valid ICD-9-CM diagnosis code. 
To 
Any valid diagnosis code as per the CMS ICD-9-CM master code table (ICD-9-CM Full and 
Abbreviated Code Titles): 
http://www.cms.gov/Medicare/Coding/ICD9ProviderDiagnosticCodes/codes.html. 
Suggested Data Sources 
Change third bullet to: 
•  UB-04 
Remove after third bullet: 
Note: Medicare will only accept codes listed in fields A-H 
 
 
Impacts: 
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ICD-9-CM Other Procedure Codes 
Rationale:  The verbiage used in the manual for data elements collected for all records is 
being updated. 
Description of Changes: 
Collected For 
Change to: 
CMS/The Joint Commission:  All Records  
Definition 
Change to: 
The other or secondary ICD-9-CM codes identifying all significant procedures other than the 
principal procedure. 
 
Allowable Values 
Change from: 
Any valid ICD-9-CM procedure code. 
To 
Any valid procedure code as per the CMS ICD-9-CM master code table (ICD-9-CM Full and 
Abbreviated Code Titles): 
http://www.cms.gov/Medicare/Coding/ICD9ProviderDiagnosticCodes/codes.html. 
Suggested Data Sources 
Change third bullet to: 
•  UB-04 
Inclusion Guidelines for Abstraction 
Change to: 
None 
 
Impacts: 
ICD-9-CM Other Procedure Dates 
Rationale:  The verbiage used in the manual for data elements collected for all records is 
being updated. 
Description of Changes: 
Suggested Data Sources 
Change last bullet to: 
•  UB-04 
 
Impacts: 
ICD-9-CM Principal Diagnosis Code 
Rationale:  The verbiage used in the manual for data elements collected for all records is 
being updated. 
Description of Changes: 
Collected For 
Change to: 
CMS/The Joint Commission:  All Records  
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Definition 
Change to: 
The ICD-9-CM diagnosis code that is primarily responsible for the admission of the patient to 
the hospital for care during this hospitalization.  
 
Allowable Values 
Change from: 
Any valid ICD-9-CM diagnosis code 
To 
Any valid diagnosis code as per the CMS ICD-9-CM master code table (ICD-9-CM Full and 
Abbreviated Code Titles): 
http://www.cms.gov/Medicare/Coding/ICD9ProviderDiagnosticCodes/codes.html. 
Suggested Data Sources 
Change third bullet to: 
•  UB-04 
Inclusion Guidelines for Abstraction 
Change to: 
None 
Exclusion Guidelines for Abstraction 
Change to: 
None  
 
Impacts: 
ICD-9-CM Principal Procedure Code 
Rationale:  The verbiage used in the manual for data elements collected for all records is 
being updated. 
Description of Changes: 
Collected For 
Change to: 
CMS/The Joint Commission:  All Records  
 
Definition 
Change to: 
The principal procedure is the procedure performed to definitive treatment rather than 
diagnostic or exploratory purposes or which is necessary to take care of the complication. 
Allowable Values 
Change from: 
Any valid ICD-9-CM procedure code. 
To 
Any valid procedure code as per the CMS ICD-9-CM master code table (ICD-9-CM Full and 
Abbreviated Code Titles): 
http://www.cms.gov/Medicare/Coding/ICD9ProviderDiagnosticCodes/codes.html. 
Notes for Abstraction 
Change to: 
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None 
Suggested Data Sources 
Change third bullet to: 
•  UB-04 
Inclusion Guidelines for Abstraction 
Change to: 
None  
 
Impacts: 
ICD-9-CM Principal Procedure Date 
Rationale:  The verbiage used in the manual for data elements collected for all records is 
being updated. 
Description of Changes: 
Suggested Data Sources 
Change last bullet to: 
•  UB-04 
 
Impacts: 
ICU Admission or Transfer 
Rationale:  The PN-3a and PN-3b measures are being removed at the direction of CMS and 
based on the IPPS Fiscal Year 2014 Final Rule. 
Description of Changes: 
Collected For 
Remove under ‘The Joint Commission Only’:  
PN-3a 
 
Remove: 
CMS Voluntary Only: PN-3a 
 
 
Impacts: 
ICU VTE Prophylaxis  
Rationale:  The need for clarification of documentation that is acceptable for these data 
elements was identified through review of clinical scenarios by the Technical Advisory Panel. 
Description of Changes: 
Definition 
Remove the word “initially” 
Suggested Data Collection Question 
Remove the word “initially” 
Notes for Abstraction 
Change to: 
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•  No value should be selected more than once. If a value of “A” is selected, no other 
selection should be recorded.  
Example:  
Lovenox is ordered and substituted with dalteparin. Only abstract value “2” once, 
as both are LMWH. 
•  Abstract ALL VTE prophylaxis(s) that was administered the day of or the day after ICU 
admission or the day of or the day after Surgery End Date for surgeries that start the 
day of or the day after ICU admission. If no ICU VTE prophylaxis was administered 
during this timeframe, select value “A.” 
•  Selection of allowable values 1-8 includes any prophylaxis that was administered in the 
allowable time frame.  
Example:  
If a patient was admitted to ICU on 12/8/20xx and had bilateral GCS applied at 
13:00 on 12/08/20xx and LMWH was administered at 22:00 on 12/9/20xx, select 
Values “2” and “4.”  
•  If one pharmacological medication is ordered and another medication is substituted 
(such as per pharmacy formulary substitution or protocol), abstract the medication 
administered. Note: No copy of the formulary or protocol is required in the medical 
record. 
Example: 
Lovenox is ordered and not received and is substituted with fondaparinux 
sodium, which is received by the patient. Abstract fondaparinux sodium as Value 
“5” for ICU VTE Prophylaxis and abstract the date it was administered for ICU 
VTE Prophylaxis Date. 
•  If the patient received one of the pharmacologic anticoagulation medications for other 
reasons, select the allowable value that was administered during the specified 
timeframe.  
Example:  
If the patient received warfarin for atrial fibrillation on the day of ICU admission, 
select Value “6.” 
•  Only select prophylaxis if there is documentation that it was administered. 
Documentation in the progress notes under assessment/Plan: “DVT prophylaxis – 
SCD/Teds” is not enough to select Values “3” and “4.” 
•  Application of mechanical prophylaxis may be documented by any personnel.  
Example: 
  Nursing assistant documentation of IPC application during the allowable  
  timeframe is acceptable. 
 
Impacts: 
ICU VTE Prophylaxis Date 
Rationale:  The need for clarification of documentation that is acceptable for these data 
elements was identified through review of clinical scenarios by the Technical Advisory Panel. 
Description of Changes: 
Definition 
Remove the word “initial” 
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Suggested Data Collection Question 
Remove the word “initial” 
 
Notes for Abstraction 
Change first bullet to: 
•  The earliest date associated with a form of prophylaxis other than aspirin should be 
entered. 
Example:  
If the patient was admitted on 12/8/20xx and aspirin was administered at 13:00 
on 12/8/20xx and LMWH was administered at 02:00 on 12/9/20xx, record the 
12/9/20xx date.  
 
Suggested Data Sources 
Change to: 
•  Circulator’s notes  
•  Graphic/flow sheets  
•  Medication administration record  
•  Nursing notes  
•  Operative notes  
•  Physician notes  
•  Preoperative nursing notes  
•  Progress notes  
 
Impacts: 
Initial ECG Interpretation 
Rationale:  Cases with an initial ECG finding of "Not a STEMI" should be excluded from the 
reperfusion measures. 
Description of Changes: 
Notes for Abstraction 
Change sixth bullet to: 
•  If documentation regarding an Inclusion term is contradictory within the same interpretation 
or between different interpretations, select “No.”  
Examples:   
o  “ST-elevation” and “No ST-elevation” 
o  "Acute anterior MI" and "no acute MI" 
Note: Documentation such as "STEMI" and "No ST elevation" should not be considered 
contradictory, for the purposes of this data element.  
 
Exclusion Guidelines for Abstraction - ST-segment elevation 
Add new first bullet: 
•  Documentation of the absence of STEMI (in reference to the ECG performed closest to 
arrival) - e.g., “No STEMI,” “not a STEMI,” “not consistent with STEMI,” “not diagnostic of 
STEMI” 
 
Impacts: 
Initial ECG Interpretation 
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Rationale:  The latest ACCF/AHA STEMI clinical guidelines no longer support taking LBBB on 
the presenting ECG as a criterion for candidacy for acute reperfusion. 
Description of Changes: 
Definition 
Change to: 
ST-segment elevation based on the documentation of the electrocardiogram (ECG) performed 
closest to hospital arrival. The normal ECG is composed of a P wave (atrial depolarization), Q, 
R, and S waves (QRS complex, ventricular depolarization), and a T wave (ventricular 
repolarization). The ST-segment, the segment between the QRS complex and the T wave, 
may be elevated when myocardial injury (AMI) occurs. 
 
Suggested Data Collection Question 
Change to: 
Is there documentation of ST-segment elevation on the electrocardiogram (ECG) performed 
closest to hospital arrival? 
 
Allowable Values 
Change from: 
Y (Yes)   ST-segment elevation or a LBBB on the interpretation of the 12-lead ECG 
performed closest to hospital arrival.  
 
N (No)   No ST-elevation or LBBB on the interpretation of the 12-lead ECG 
performed closest to hospital arrival, no interpretation or report available 
for the ECG performed closest to hospital arrival or unable to determine 
from medical record documentation. 
To: 
Y (Yes)   ST-segment elevation on the interpretation of the 12-lead ECG performed 
closest to hospital arrival.  
 
N (No)   No ST-elevation on the interpretation of the 12-lead ECG performed 
closest to hospital arrival, no interpretation or report available for the ECG 
performed closest to hospital arrival or unable to determine from medical 
record documentation. 
 
 
Notes for Abstraction 
Change second bullet to: 
•  Do not measure ST-segments from the tracing itself. 
 
Remove seventh bullet: 
•  If at least one interpretation describes an LBBB as old, chronic, or previously seen, or 
states LBBB and "no changes," "unchanged," "no acute changes," "no new changes," 
or "no significant changes" when compared to a prior ECG, all LBBB findings should be 
disregarded.  
 
Inclusion Guidelines for Abstraction 
Remove: 
Left bundle branch block (LBBB) 
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•  Intraventricular conduction delay of LBBB type 
•  Variable LBBB 
 
Exclusion Guidelines for Abstraction 
Remove: 
Left bundle branch block (LBBB) 
•  Incomplete left bundle branch block (LBBB) 
•  Left bundle branch block (LBBB), or any of the other left bundle branch block inclusion 
terms, described using one of the negative modifiers or qualifiers listed in Appendix H, 
Table 2.6, Qualifiers and Modifiers Table (except “possible”) 
•  Left bundle branch block (LBBB), or any of the other left bundle branch block inclusion 
terms, with any mention of pacemaker/pacing (unless atrial only or nonfunctioning 
pacemaker) in one interpretation 
 
Impacts: 
INR Value 
Rationale:  The time frame for documentation reflecting the intended reason for not ordering 
overlap therapy needed to be defined. The time frame for determining INR value was defined 
and examples provided. 
Description of Changes: 
Definition 
Change to: 
Documentation of an international normalized ratio (INR) value greater than or equal to 2.0 on 
the day of or the day after the last dose of the pareneteral anticoagulation therapy. This value 
correlates to the ability of the blood to clot. 
 
Suggested Data Collection Question 
Change to: 
Was there documentation of an INR value greater than or equal to 2.0 on the day of or the day 
after the last dose of the parenteral anticoagulation therapy? 
 
Allowable Values 
Change from: 
Y (Yes)   There is documentation of an INR result greater than or equal to 2 prior to  
  discontinuation of the parenteral anticoagulation therapy. 
 
N (No)  There is no documentation of an INR result greater than or equal to 2 prior to 
  discontinuation of the parenteral anticoagulation therapy or unable to determine 
  from medical record documentation. 
To: 
Y (Yes)   There is documentation of an INR result greater than or equal to 2.0 on the day of 
  or the day after the last dose of the parenteral anticoagulation therapy. 
 
N (No)   There is no documentation of an INR result greater than or equal to 2.0 the day of 
  or the day after the last dose of the parenteral anticoagulation therapy or unable to 
  determine from medical record documentation. 
 
Notes for Abstraction 
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Change to: 
•  To determine the value for this data element, review the INR values the day of or the 
day after the last dose of the parenteral anticoagulation therapy was administered. If 
any result is greater than or equal to 2.0, select “Yes.” 
Examples:  
o  On 1/1/20XX, after four days of overlap therapy, the INR is 1.8. On 1/2/20XX, the 
patient received enoxaparin, the INR is 2.0. Select “Yes” because the INR was 
equal to 2.0 on the day of or the day after the last dose of the parenteral 
anticoagulation therapy. 
o  On 1/1/20XX, after four days of overlap therapy, the INR is 2.0. The last dose of 
dalteparin was on 1/2/20XX , on the same day, the INR was 1.8. The patient is 
discharged without parenteral anticoagulation therapy.  Select “No” because the 
INR was not greater than or equal to 2.0 the day of or the day after the last dose 
of the parenteral anticoagulation therapy.  
o  On 1/1/20XX, after five days of overlap therapy, the last dose of heparin is 
administered, the INR is 1.8. The patient is discharged without parenteral 
anticoagulation therapy. Select “No” because the INR was not greater than or 
equal to 2.0 on the day of or the day after the last dose of parenteral 
anticoagulation therapy.   
o  On 1/1/20XX, after seven days of overlap therapy, the INR remains less than 2.0. 
On 1/2/20XX, the patient receives the last dose of enoxaparin and the INR 
equals 2.0. Select “Yes” because the INR is greater than or equal to 2.0 on the 
day of or the day after the last dose of parenteral anticoagulation therapy. 
 
 
Impacts: 
IV Thrombolytic Initiation 
Rationale:  This change is to remove Notes for Abstraction from the data element IV 
Thrombolytic Initiation which is counter-intuitive to the measure logic. 
Description of Changes: 
Notes for Abstraction 
Remove fourth bullet:  
•  When IV thrombolytic therapy is initiated beyond 3 hours (180 min.) because a reason 
for not initiating IV thrombolytic therapy existed during the 3 hour timeframe, select “No”. 
Examples: 
o  Patient arrives in the emergency department within 2 hours of time last known 
well. Blood pressure 195/110 mmHg on arrival. Physician documents that patient 
is within the t-PA window, but blood pressure is an issue. Elevated blood 
pressure treated prior to t-PA administration. IV thrombolytic therapy 
administered at 3 hours and 30 minutes from time last known well. 
o  Patient arrives in the emergency department within 2 hours of time last known 
well and refuses t-PA. Family arrives and after further discussion with them, 
patient consents to t-PA. IV thrombolytic therapy administered 4 hours later. 
 
Suggested Data Sources 
Add new bullet: 
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•  IV flow sheets 
 
Exclusion Guidelines for Abstraction 
Add new bullet: 
•  Thrombolytic administration to flush, open or maintain patency of a central line, e.g., PICC 
line. 
 
Impacts: 
Last Known Well 
Rationale:  This change is to clarify the abstraction guidelines for data elements that generate 
the majority of stroke abstraction questions and ease the burden of abstraction. 
Description of Changes: 
Notes for Abstraction 
Change to:  
•  Select  “Yes” if BOTH a Date Last Known Well  and a Time Last Known Well are  
documented. 
•  Select “No” if there is ANY physician/APN/PA documentation that Last Known Well is 
“UNKNOWN.” Documentation must explicitly state that the Time Last Known Well is 
unknown/uncertain.   
•  If the time last known well is clearly greater than 2 hours prior to hospital arrival AND no 
specific time is documented, select “No.” 
Example: 
“Patient OK last night.”  Select “No” because no other documentation of a specific 
time/time range/time reference was present in the medical record and the time is 
required for the Time Last Known Well. 
•  Documentation of Last Known Well or stroke symptoms that occurred at a date or time 
following hospital arrival (e.g., in-house stroke), select “No.”    
Suggested Data Sources 
Change to: 
•  Ambulance record 
•  Code Stroke form/template  
•  Emergency department records 
•  History and physical 
•  IV flow sheets 
•  Medication administration record 
•  Nursing flow sheets  
•  Progress notes 
•  Transfer sheet 
 
Remove: 
Excluded Data Sources: 
•  Discharge summary 
 
Impacts: 
Measure Category Assignment 
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Rationale:  Changes are being made to provide clarification regarding measures for which 
better quality is associated with a lower score or numerator. Additional clarification is being 
provided regarding how the records are included in the measure numerator and/or 
denominator for aggregate data for such inverse measures. 
Description of Changes: 
Allowable Values 
Add after first paragraph for “Category D - In Measure Population”: 
Note: For measures for which better quality is associated with a lower score or numerator, i.e., 
VTE-6 and PC-01, a Measure Category Assignment of “D” means that the appropriate care 
was provided and the intent of the measure was met. For aggregate data, the EOC record will 
be included in the measure denominator only. 
Add after first paragraph for “Category E - In Numerator Population”: 
Note: For measures for which better quality is associated with a lower score or numerator, i.e., 
VTE-6 and PC-01, a Measure Category Assignment of “E” means that the appropriate care 
was not provided and the intent of the measure was not met.   
For aggregate data, the EOC record will be included in both the measure numerator and 
denominator. 
 
Impacts: 
Monitoring Documentation 
Rationale:  Clinical scenarios were presented to the VTE Technical Advisory Panel, and it was 
determined that the measure did not allow for exceptions to the data element. 
Description of Changes: 
Notes for Abstraction 
Add fifth bullet: 
•  If there is physician/APN/PA or pharmacist documentation of an explicit reason for not 
using documentation such as a nomogram or protocol, linked to the heparin order, 
select “Yes.”  
Example: 
Do not use heparin protocol, MD to manage heparin drip, select “Yes.” 
 
Suggested Data Sources 
Add: 
•  Protocol for heparin management 
•  Nomogram for heparin management 
•  Laboratory values 
Change “Exception” to: 
Exception (Physician/APN/PA or pharmacist documentation not required) 
Nursing documentation on pathways 
 
Impacts: 
Patient HIC# 
Payment Source 
Postal Code 
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Rationale:  The verbiage used in the manual for data elements collected for all records is 
being updated. 
Description of Changes: 
Suggested Data Sources 
Change last bullet to: 
•  UB-04 
 
Impacts:   
Pneumonia Diagnosis: ED/Direct Admit 
Rationale:  This change is to provide clarification to the abstractor and to make the data 
element more consistent with the pneumonia measures. 
Description of Changes: 
Definition 
Change to: 
Documentation of the diagnosis of pneumonia either as the Emergency Department 
diagnosis/impression, or as an admission diagnosis/impression for the direct admit patient 
within 24 hours after arrival to the hospital. 
 
Notes for Abstractions 
Add new first bullet: 
•  Only consider diagnoses that have been documented by a Physician/APN/PA within 24 
hours of patient’s arrival at the hospital. Do not accept any diagnosis that is documented 
greater than 24 hours after patient’s arrival to the hospital. 
 
Change example in seventh bullet to: 
ED diagnosis “Pneumonia vs. aspiration pneumonia.” 
 
Add new eighth bullet: 
•  If there is documentation of a diagnosis of pneumonia and a diagnosis of “aspiration 
pneumonia” on the same or different Only Acceptable Sources, select value “2”. 
Example: 
Admit H&P: Clinical Diagnosis/Impression: Pneumonia; Admitting Physician 
Orders: Diagnosis: Aspiration Pneumonia 
 
 
 
Patients seen in the Emergency Department 
Change third bullet to: 
•  For the purposes of this data element, the “ED form” is an area or section within the ED 
record for the physician/APN/PA to list diagnoses or impressions. 
 
Remove fourth bullet: 
•  In the ED, the diagnosis of pneumonia should be taken from a section that is specifically 
designated for the physician/APN/PA to list diagnoses or impressions. 
 
Remove eighth bullet: 
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•  If pneumonia is listed as a diagnosis/impression on the ED form by any 
physician/APN/PA, select value “1.” No further review of additional suggested data 
sources is needed (e.g., the admit order or admit note).  
 
Change eleventh bullet to: 
•  Those cases where the patient is seen in the emergency department but the medical 
record does not contain an ED form, which is different than just leaving the form blank 
(e.g., the physician treating the patient in the ED documented everything on an admit 
note) are limited to the following ONLY ACCEPTABLE SOURCES: Admitting notes, 
Admitting physician orders and Admit H&P. 
 
Direct Admits 
Change fourth bullet to: 
•  When the patient is a direct admit and is not seen in the ED, the diagnosis of 
pneumonia should be found on the following ONLY ACCEPTABLE SOURCES to select 
value 1: Admitting notes, Admitting physician orders, Admit History & Physical (H&P). 
 
Remove eighth bullet: 
•  Any of the ONLY ACCEPTABLE SOURCES can be used without a date or time except 
for an Admit H&P for a direct admit patient. This must be written or dictated within 24 
hours of hospital arrival. 
 
Change ninth bullet to: 
•  An undated and/or untimed document is not an acceptable source. 
 
Suggested Data Sources 
Direct Admit 
Change first bullet to: 
o  Admit History & Physical (H&P) 
 
Impacts: 
Pre-Arrival Lipid-Lowering Agent 
Rationale:  The change is to correct a typographical error.   
Description of Changes: 
Collected For 
Change to: 
CMS/The Joint Commission:  STK-6 
Impacts: 
Prescription for Alcohol or Drug Disorder Medication 
Rationale:   Patients without a residence in the USA are not a part of the measure population, 
so only allowable value “3” should be selected.   
Description of Changes: 
Allowable Values 
Change value 3 from: 
A prescription for an FDA-approved medication for alcohol or drug disorder was not offered at 
discharge because the patient’s residence is not in the USA. 
Specifications Manual for Hospital Inpatient Quality Measures  Page 33 
Discharges 01-1-15 (1Q15) through 09-30-15 (3Q15) Release Notes Version 4.4 
To: 
The patient’s residence is not in the USA. 
Notes for Abstraction 
Add new fourth bullet: 
If the patient does not have a residence in the USA, value “3” must be selected. 
 
Impacts: 
Prescription for Tobacco Cessation Medication 
Rationale:   Patients without a residence in the USA are not a part of the measure population, 
so only allowable value “3” should be selected.   
Description of Changes: 
Allowable Values: 
Change value 3 from: 
A prescription for an FDA-approved medication for alcohol or drug disorder was not offered at 
discharge because the patient’s residence is not in the USA. 
To: 
The patient’s residence is not in the USA. 
Notes for Abstraction: 
Add new 5th bullet: 
If the patient does not have a residence in the USA, value “3” must be selected. 
 
Impacts: 
Reason for Discontinuation of Parenteral Therapy 
Rationale:  Clinical scenarios presented to the Technical Advisory Panel (TAP) justified the 
need for defined time frames, and the need for examples and clarifications to capture 
acceptable documentation for these data elements. 
Description of Changes: 
Data Element Name 
Change to: 
Reason for Discontinuation of Parenteral AnticoagulationTherapy 
Definition 
Change to: 
Documentation of a reason for discontinuation of the parenteral anticoagulation therapy by a 
physician/APN/PA or pharmacist on the same day or the day before the order for the 
discontinuation.  
Suggested Data Collection Question 
Change to: 
Is there a reason for discontinuation of the parenteral anticoagulation therapy, documented by 
a physician/APN/PA or pharmacist on the same day or the day before the order for the 
discontinuation? 
Allowable Values 
Change from: 
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Y (Yes)  There is a reason documented by a physician/APN/PA or pharmacist for 
discontinuation of the parenteral therapy. 
N (No)  There is no reason documented by a physician/APN/PA or pharmacist for 
discontinuation of the parenteral therapy or unable to determine from medical 
record documentation. 
To: 
Y (Yes)  There is a reason documented for discontinuation of the parenteral 
anticoagulation therapy, by a physician/APN/PA or pharmacist on the same day 
or the day before the order for the discontinuation. 
N (No)  There is no reason for discontinuation of the parenteral anticoagulation therapy 
documented by a physician/APN/PA or pharmacist on the same day or the day 
before the order for the discontinuation or unable to determine from medical 
record documentation. 
 
Notes for Abstraction 
Change to: 
•  Reasons for discontinuation of parenteral anticoagulation therapy must be explicitly 
documented or clearly implied. The explicit reason for the discontinuation of the 
parenteral anticoagulation therapy must be documented by the 
physician/APN/PA/pharmacist on the same day or the day before the order for 
discontinuation.  
•  If reasons are not mentioned in the context of the discontinuation of the parenteral 
anticoagulation therapy, do not make inferences. 
Examples: 
o  Actively Bleeding -  Anticoagulation Contraindicated 
o  Severe anemia, discontinue heparin 
o  GI Bleed – Discontinue enoxaparin  
o  D/C enoxaparin rectal bleed 
o  Discontinue dalteparin, patient scheduled for surgery today 
•  Do not infer reasons based on laboratory values alone, ONLY physician/APN/PA or 
pharmacist documentation of the specified reason is acceptable. 
•  Documentation of reasons synonymous with a high or supratherapeutic INR or an INR 
>3.0 is acceptable for discontinuation of parenteral anticoagulation therapy when 
documented by a physician/APN/PA or pharmacist.   
Examples: 
o  D/C enoxaparin, INR 6.0, select “Yes.” 
o  D/C heparin, INR supratherapeutic, select “Yes.” 
•  For patient with less than five days of overlap therapy: 
o  Additional documentation is needed to support the reason for discontinuation of 
parenteral anticoagulation therapy. 
Example: 
Dalteparin and warfarin are started on 01/01/20XX. On 01/03/20XX patient 
is discharged home on warfarin alone, select “No.” The patient has not 
received five days of parenteral anticoagulation therapy. 
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o  For documentation of therapeutic INR or an INR with a value equal to 2.0-3.0 
(target range of 2.5), additional documentation is needed to support the reason to 
select “Yes.” 
Examples: 
  INR 2.5 Discharge home, select “No.” There is no additional 
documentation of a reason for the discontinuation of the parenteral 
anticoagulation therapy. 
  INR 2.5 patient bleeding, D/C IV heparin, select “Yes.” There is additional 
documentation of a reason for the discontinuation of the parenteral 
anticoagulation therapy. 
  Discontinue enoxaparin, patient INR is therapeutic, select “No.” There is 
no additional documentation of a reason for the discontinuation of the 
parenteral anticoagulation therapy. 
•  For patients with five or more days of overlap therapy and INR <2.0, explicit 
documentation of a reason for discontinuation of the parenteral anticoagulation therapy 
is needed to select “Yes.” 
Examples: 
o  Discontinue enoxaparin therapy, INR 1.7, home on warfarin, select “No.” The INR 
value is < 2.0. 
o  Discontinue enoxaparin, INR 1.7, patient at risk for bleeding, select “Yes.” There 
is additional documentation of a reason for the discontinuation of the parenteral 
anticoagulation therapy. 
•  Overlap therapy days are calculated by taking the Parenteral Anticoagulant End Date 
minus the Overlap Therapy Start Date. 
•  Documentation that the patient is allergic or intolerant to ALL parenteral anticoagulation 
therapy is acceptable. An allergy or adverse reaction to ONE type of parenteral 
anticoagulant is NOT a reason for not administering all parenteral anticoagulants. 
Another medication can be ordered. 
•  Substitution of one parenteral anticoagulation drug for another parenteral drug is not 
considered discontinuation of parenteral anticoagulation therapy. 
Example: 
If a patient was on heparin subcutaneous and was changed to fondaparinux sodium 
subcutaneous on day 3, the patient is discharged on fondaparinux sodium, select “No.” 
 
Add: 
Exceptions to physician/APN/PA or pharmacist documentation only:  
•  Patient refusal of parenteral anticoagulation therapy during hospitalization or at 
discharge is a reason for discontinuation and may be documented by a nurse. 
•  Documentation that the patient is allergic or intolerant to ALL parenteral anticoagulation 
therapy is acceptable.  
 
 
Suggested Data Sources 
Change: 
ONLY PHYSICIAN/APN/PA or PHARMACIST DOCUMENTATION OF A REASON FOR 
DISCONTINUING PARENTERAL THERAPY 
To: 
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ONLY PHYSICIAN/APN/PA or PHARMACIST DOCUMENTATION OF A REASON FOR 
DISCONTINUING PARENTERAL ANTICOAGULATION THERAPY 
 
Excluded Data Sources 
Change to: 
Any documentation dated/timed after discharge. 
 
Inclusion Guidelines for Abstraction 
Change to: 
Documentation must be present on the same day or the day before the order for the 
discontinuation of the parenteral anticoagulation therapy.  
•  Documentation of active bleeding  
•  Documentation of a plan for surgery  
•  Documentation of a plan for blood transfusion  
•  Administration of Oral Factor Xa Inhibitors   
o  Xarelto or rivaroxaban 
o  Eliquis or apixaban  
•  Documentation that patient is not a candidate for anticoagulation therapy 
•  Documentation of thrombocytopenia  
 
Exclusion Guidelines for Abstraction 
Remove first bullet: 
•  A therapeutic INR value equal to 2.0-3.0 (target range of 2.5) without additional 
documentation that notes a decision was made to discontinue parenteral therapy. 
 
Impacts:  N/A 
Rationale:  This change is to adjust the measure flow logic and add a new data element that 
will exclude cases who received IV thrombolytic therapy in 3 to 4.5 hours because a reason 
delayed initiation within 3 hours. 
Description of Changes: 
Add new data element: 
Reason for Extending the Initiation of IV Thrombolytic 
 
Impacts:  N/A 
Rationale:  The Technical Advisory Panel reviewed clinical scenarios presented and 
determined that a timeframe was needed for documentation to be acceptable for these data 
elements. An additional data element was added to further define reasons for not providing 
prophylaxis to records in VTE-6 Hospital Acquired VTE. 
Description of Changes: 
Add new data element: 
Reason for No Administration of VTE Prophylaxis 
 
 
 
 
Impacts: 
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Reason for No Overlap Therapy 
Rationale:  The time frame for documentation reflecting the intended reason for not ordering 
overlap therapy needed to be defined. The time frame for determining INR value was defined 
and examples provided. 
Description of Changes: 
Definition 
Change to: 
Physician/APN/PA/pharmacist documentation on the day of or the day after the VTE 
Diagnostic Test, of a reason why parenteral anticoagulation therapy and warfarin were not 
administered on the same day. 
 
Suggested Data Collection Question 
Change to: 
Is there physician/APN/PA or pharmacist documentation on the day of or the day after the VTE 
Diagnostic Test, of a reason why parenteral anticoagulation therapy and warfarin were not 
administered on the same day? 
 
Allowable Values 
Change from: 
Y (Yes)  There is Physician/APN/PA/Pharmacist documentation of a reason why 
  parenteral anticoagulation therapy and warfarin were not administered on the 
  same day. 
 
N (No)  There is no Physician/APN/PA/Pharmacist documentation of a reason why 
  parenteral anticoagulation therapy and warfarin were not administered on the 
  same day or unable to determine from medical record documentation. 
To: 
Y (Yes)  There is physician/APN/PA/pharmacist documentation on the day of or the day 
  after the VTE Diagnostic Test of a reason why parenteral anticoagulation therapy 
  and warfarin were not administered on the same day. 
 
N (No)  There is no physician/APN/PA/pharmacist documentation on the day of or the 
  day after the VTE Diagnostic Test of a reason why parenteral anticoagulation 
  therapy and warfarin were not administered on the same day or unable to 
  determine from medical record documentation. 
 
Notes for Abstraction 
Change to: 
•  The explicit reason for no overlap therapy must be documented by the 
physician/APN/PA/pharmacist on the day of or the day after the VTE Diagnostic Test. 
Refer to the data element VTE Diagnostic Test for a list of acceptable tests.  
•  Reasons (other than those listed in the inclusion guidelines) not mentioned in the 
context of NO overlap therapy are not acceptable.   
•  Documentation by the physician/APN/PA or pharmacist must state the reason for no 
overlap therapy.  
Examples: 
o  No overlap therapy, patient bleeding. 
o  No bridge therapy, GI bleed. 
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o  Intolerance to parenteral anticoagulation therapies 
•  If there is questionable documentation regarding the reason for no overlap therapy, 
select “No.”  
Example: 
The physician documents that the patient had a bleeding nose on arrival to the 
emergency department. Three days into the admission, a VTE Diagnostic Test was 
performed and VTE was confirmed. No overlap therapy was administered during the 
hospitalization. There is documentation of a bleeding nose on arrival, but NO 
documentation of a reason for no overlap therapy after the VTE was diagnosed. Select 
“No.”  
•  Documentation that the patient is allergic or intolerant to ALL parenteral anticoagulation 
therapy is acceptable. An allergy or adverse reaction to ONE type of anticoagulant is 
NOT a reason for not administering all anticoagulants. Another medication can be 
ordered.  
•  For VTE Diagnostic Tests performed prior to arrival, documentation must be present the 
day of or the day after arrival.  
 
Add: 
Exceptions to physician/APN/PA or pharmacist documentation only: 
•  Patient/family refusal of any or all forms of overlap therapy does not have to be 
documented by a physician/APN/PA or pharmacist. Refusal may be documented by a 
nurse, but should be documented within the same timeframe as overlap therapy.  
Example:  
There is documentation by the nurse that the patient refused heparin during the 
timeframe for overlap therapy. Select “Yes.”  
•  Documentation that the patient is allergic or intolerant to ALL parenteral anticoagulation 
therapy may be documented by a nurse.  
 
Change “SUGGESTED DATA SOURCES FOR PATIENT REFUSAL (other than 
physician/APN/PA or pharmacist) documentation of a reason for not administering Overlap 
Therapy as above):” 
To: 
SUGGESTED DATA SOURCES FOR PATIENT REFUSAL, ALLERGY OR 
ADMINISTRATION OF ORAL FACTOR Xa INHIBITOR (other than physician/APN/PA or 
pharmacist documentation): 
 
Add: 
Excluded Data Sources:   
Any documentation dated/timed after discharge. 
 
Inclusion Guidelines for Abstraction 
Change to: 
Documentation must be present on the day of or the day after the VTE Diagnostic Test : 
•  Documentation of active bleeding  
•  Documentation of a plan for surgery  
•  Documentation of a plan for blood transfusion  
•  Administration of Oral Factor Xa Inhibitors   
o  Xarelto or rivaroxaban 
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o  Eliquis or apixaban 
•  Documentation that patient is not a candidate for anticoagulation therapy 
 
Impacts: 
Reason for No VTE Prophylaxis – Hospital Admission 
Rationale:  The need for clarification of documentation that is acceptable for these data 
elements was identified through review of clinical scenarios by the Technical Advisory Panel. 
Description of Changes: 
Definition 
Change to: 
Physician/APN/PA or pharmacist documentation why mechanical AND pharmacological VTE 
prophylaxis was not administered at hospital admission. 
The two circumstances in which one can select “Yes” to this data element are: 
•  There is explicit documentation indicating that the patient is at low risk for VTE. 
•  There is explicit documentation of a contraindication to mechanical prophylaxis AND 
documentation of a contraindication to pharmacological prophylaxis. 
 
Suggested Data Collection Question 
Change to: 
Is there physician/APN/PA or pharmacist documentation why VTE prophylaxis was not 
administered at hospital admission? 
 
Allowable Values 
Change from: 
Y (Yes)  There is documentation why VTE prophylaxis was not administered at hospital 
admission. 
 
N (No)  There is no documentation why VTE prophylaxis was not administered at 
hospital admission or unable to determine from medical record documentation. 
To: 
Y (Yes)  There is physician/APN/PA or pharmacist documentation why VTE prophylaxis 
was not administered at hospital admission. 
 
N (No)  There is no physician/APN/PA or pharmacist documentation why VTE 
prophylaxis was not administered at hospital admission or unable to determine 
from medical record documentation. 
 
Notes for Abstraction 
Change to: 
•  If a patient received prophylaxis as per the data element VTE Prophylaxis, select “No.” 
•  If a risk assessment is used, and notes anything other than low risk (e.g. intermediate 
risk, moderate risk, or high risk), additional documentation must be present to answer 
“Yes.” Explicit documentation of a contraindication to mechanical AND 
contraindication to pharmacological prophylaxis must be addressed. 
o  If there is physician documentation of “bleeding, no pharmacologic prophylaxis,” 
the chart must be reviewed for documentation about a reason for no mechanical 
prophylaxis in order to select “Yes.”  
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Examples: 
  Bleeding, no pharmacologic prophylaxis, no mechanical prophylaxis. 
   Active GI bleed – low molecular weight heparin contraindicated, no 
mechanical prophylaxis needed. 
•  To select “Yes” for this data element, documentation must be dated from arrival to the 
day after hospital admission or surgery end date. Documentation written after arrival but 
prior to admission is acceptable. 
•  If reasons are not mentioned in the context of VTE prophylaxis, do not make 
inferences (e.g., do not assume that VTE Prophylaxis was not administered because of 
a bleeding disorder unless documentation explicitly states so). 
Example: 
Physician/APN/PA documentation of bleeding risk, review the chart for 
documentation about reasons for no mechanical AND reasons for no 
pharmacological VTE Prophylaxis. 
•  Documentation that the patient is ambulating without mention of VTE prophylaxis is 
insufficient.  Do not infer that VTE prophylaxis is not needed unless explicitly 
documented. 
•  For patients with a reason for no pharmacologic or no mechanical prophylaxis and an 
order for ANY prophylaxis that was NOT administered without a reason (e.g. patient 
refusal), select “No.” 
•  If two physicians/APN/PA or pharmacists document conflicting or questionable needs 
for prophylaxis, select “No.” 
•  For ONLY those patients determined to be AT LOW RISK for VTE: 
o  If documentation of “No VTE Prophylaxis needed” is written, then it will be 
inferred that both mechanical and pharmacological options were not indicated for 
the patient, select “Yes.” 
Example: 
Low Risk, No VTE Prophylaxis, select “Yes.” 
o  A completed risk assessment within this timeframe determining the patient is low 
risk is acceptable for this data element, select “Yes.” Risk Assessment forms may 
be initiated and completed by a nurse. 
o  If there are multiple completed risk assessments with conflicting outcomes and 
prophylaxis was NOT administered within this timeframe, select “No.” 
o  Any completed VTE risk assessment or physician/APN/PA or pharmacist 
documentation indicating “low risk” is acceptable. 
 
Change “Exceptions” to: 
Exceptions to physician/APN/PA or pharmacist documentation of a reason for no mechanical 
or pharmacological VTE prophylaxis: 
•  If Comfort Measures Only (CMO) was documented after the day after arrival (Day 1) but 
by the day after hospital admission or surgery end date for surgeries that start the day 
of or the day after hospital admission, select “Yes.”  
  Examples:  
o  Patient arrives in the ED on 06/01/20xx but is in observation until admission to 
the hospital on 06/03/20xx. If CMO is documented by 06/04/20xx, select “Yes.”  
o  The patient was admitted on 5/31/20xx and the surgery end date was 
06/01/20xx, select “Yes” if CMO was documented by 06/02/xx. 
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•  Patient/family refusal may be documented by a nurse, but should be documented within 
the same timeframe as the reason for no VTE prophylaxis. Patient/family refusal of any 
form of prophylaxis is acceptable.  
Example: 
Patient refused heparin, select “Yes.” 
 
For patients on anticoagulants: 
•  For patients on continuous IV heparin therapy the day of or day after hospital admission, 
select “Yes.” 
•  If warfarin is listed as a home or current medication, select “Yes.” 
•  For patients receiving anticoagulant therapy for atrial fibrillation or for other conditions 
(e.g. angioplasty), with anticoagulation administered on the day of or the day after 
hospital admission, select “Yes.” 
•  Documentation that the patient is adequately anticoagulated or already anticoagulated, 
select “Yes.” 
Examples: 
o  Patient is already anticoagulated, taking Coumadin at home prior to admission. 
o  INR therapeutic and adequately anticoagulated at this time. 
•  Documentation synonymous with “abruptly reversed anticoagulation for major bleeding,” 
select “Yes.” 
Examples: 
o  INR reversal for major bleeding. 
o  Reverse anticoagulation for intracranial hemorrhage. 
STK 
Stroke patients require a documented reason for not administering another form of 
prophylaxis when graduated compression stockings (GCS) or aspirin are the ONLY form 
of VTE prophylaxis administered. 
VTE 
VTE patients require a documented reason for not administering another form of 
prophylaxis when aspirin is the ONLY form of VTE prophylaxis administered. 
 
Inclusion Guidelines for Abstraction 
Change first bullet to: 
•  Patient at low risk for VTE, no prophylaxis needed 
 
Change third bullet to: 
•  Patient/family refusal of VTE Prophylaxis 
 
Add: 
Refer to Appendix H, Table 2.7 Anticoagulation Therapy for Atrial Fibrillation and Other 
Conditions. 
 
Exclusion Guidelines for Abstraction 
Change to: 
Aspirin alone is not an acceptable form of VTE prophylaxis in the VTE and STK population. 
 
Impacts: 
Reason for No VTE Prophylaxis – ICU Admission 
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Rationale:  The need for clarification of documentation that is acceptable for these data 
elements was identified through review of clinical scenarios by the Technical Advisory Panel. 
Description of Changes: 
Definition 
Change to: 
Physician/APN/PA or pharmacist documentation why mechanical AND pharmacologic VTE 
prophylaxis was not administered at ICU admission/transfer. 
 
The two circumstances in which one can select “Yes” to this data element are: 
•  There is explicit documentation indicating that the patient is at “low risk” for VTE. 
•  There is explicit documentation of a contraindication to mechanical prophylaxis AND 
documentation of a contraindication to pharmacological prophylaxis. 
 
Suggested Data Collection Question 
Change to: 
Is there physician/APN/PA or pharmacist documentation why VTE prophylaxis was not 
administered at ICU admission or transfer? 
 
Allowable Values 
Change from: 
Y (Yes)  There is documentation why VTE prophylaxis was not administered at ICU 
admission/transfer. 
 
N (No)  There is no documentation why VTE prophylaxis was not administered at ICU 
admission/transfer or unable to determine from medical record documentation. 
To: 
Y (Yes)  There is physician/APN/PA or pharmacist documentation why VTE prophylaxis 
was not administered at ICU admission/transfer. 
 
N (No)  There is no physician/APN/PA or pharmacist documentation why VTE 
prophylaxis was not administered at ICU admission/transfer or unable to 
determine from medical record documentation.    
 
Notes for Abstraction 
Change to: 
•  If a patient received prophylaxis as per the data element ICU VTE Prophylaxis, select 
“No.” 
•  If a risk assessment is used, and notes anything other than low risk (e.g. intermediate 
risk, moderate risk, or high risk), additional documentation must be present to answer 
“Yes.”  Explicit documentation of a contraindication to mechanical AND 
contraindication to pharmacological prophylaxis must be addressed. 
o  If there is physician documentation of “bleeding, no pharmacologic prophylaxis,” 
the chart must be reviewed for documentation about a reason for no mechanical 
prophylaxis in order to select “Yes.” 
Examples: 
  Bleeding, no pharmacologic prophylaxis, no mechanical prophylaxis. 
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  Active GI bleed – low molecular weight heparin contraindicated, no 
mechanical prophylaxis needed. 
•  To select “Yes” for this data element, documentation must be dated from arrival to the 
day after ICU admission/transfer or surgery end date for those surgeries that start the 
day of or the day after ICU admission/transfer.  
•  Documentation written after arrival to the ICU, but prior to the decision to admit is 
acceptable. 
•  If a patient did not receive VTE prophylaxis on the medical unit due to physician 
documentation and is transferred to the ICU, another reason (even if it is the same 
reason) must be documented if no VTE prophylaxis was administered upon 
admission/transfer to ICU. 
•  If reasons are not mentioned in the context of VTE prophylaxis, do not make 
inferences (e.g., do not assume that VTE Prophylaxis was not administered because of 
a bleeding disorder unless documentation explicitly states so). 
Example: 
There is physician/APN/PA documentation of bleeding risk. Review the chart for 
documentation of reasons for no mechanical AND reasons for no pharmacological 
VTE Prophylaxis. 
•  Documentation that the patient is ambulating without mention of VTE prophylaxis is 
insufficient. Do not infer that VTE prophylaxis is not needed unless explicitly documented. 
•  For patients with a reason for no pharmacological or no mechanical prophylaxis and an 
order for ANY prophylaxis that was NOT administered without a reason (e.g. patient 
refusal), select “No.” 
•  If two physicians/APN/PA or pharmacist document conflicting or questionable needs for 
prophylaxis, select “No.” 
•  For ONLY those patients determined to be AT LOW RISK for VTE: 
o  If documentation of “No VTE Prophylaxis needed” is written, then it will be 
inferred that both mechanical and pharmacological options were not indicated 
for the patient, select “Yes.” 
Example: 
Low Risk, No VTE Prophylaxis, select “Yes.” 
o  A completed risk assessment within this timeframe determining the patient is 
low risk is acceptable for this data element, select “Yes.” Risk Assessment 
forms may be initiated and completed by a nurse. 
o  If there are multiple completed risk assessments with conflicting outcomes and 
prophylaxis was NOT administered within this timeframe, select “No.” 
o  Any completed VTE risk assessment or physician/APN/PA or pharmacist 
documentation indicating “low risk” is acceptable. 
 
Change “Exceptions” to: 
EXCEPTIONS to physician/APN/PA or pharmacist documenation of a reason for no mechanical 
or pharmacological VTE prophyhlaxis: 
•  If Comfort Measures Only (CMO) was documented after the day after arrival (Day 1) but 
by the day after ICU admission or surgery end date for surgeries that start the day of or 
the day after ICU admission, select “Yes.” 
Examples: 
o  Patient arrives in the ED on 06/01/20xx but is in observation until admission to 
the ICU on 06/03/20xx. If CMO is documented by 06/04/20xx, select “Yes.” 
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o  The patient was admitted on 05/31/20xx and the surgery end date was 
06/01/20xx, select “Yes” if CMO was documented by 06/02/20xx. 
•  Patient/family refusal may be documented by a nurse, but should be documented within 
the same timeframe as the reason for no VTE prophylaxis. Patient/family refusal of any 
form of prophylaxis is acceptable. 
Example: 
Patient refused heparin, select “Yes.” 
 
For patients on anticoagulants: 
•  For patients on continuous IV heparin therapy the day of or day after ICU admission, 
select “Yes.” 
•  If warfarin is listed as a home med, previous medication prior to admission/transfer to 
ICU, or current medication, select “Yes.” 
•  For patients receiving anticoagulant therapy for atrial fibrillation or for other conditions 
(e.g. angioplasty) with anticoagulation administered on the day of or the day after ICU 
admission/transfer, select “Yes.” 
•  Documentation that the patient is adequately anticoagulated or already anticoagulated, 
select “Yes.” 
Examples: 
o  Patient is already anticoagulated, taking Coumadin at  home prior to admission. 
o  INR therapeutic and adequately anticoagulated at this time. 
•  Documentation synonymous with “abruptly reversed anticoagulation for major 
bleeding,” select “Yes.” 
Examples: 
o  INR reversal for major bleeding. 
o  Reverse anticoagulation for intracranial hemorrhage. 
     
Inclusion Guidelines for Abstraction 
Change second bullet to: 
•  Patient at low risk for VTE, no prophylaxis needed. 
 
Change third bullet to: 
•  Patient/family refusal of VTE Prophylaxis 
 
Add: 
Refer to Appendix H, Table 2.7 Anticoagulation Therapy for Atrial Fibrillation and Other 
Conditions. 
 
Exclusion Guidelines for Abstraction 
Change to: 
Aspirin alone is not an acceptable form of VTE Prophylaxis in the VTE and STK population. 
 
 
 
Impacts: 
Reason for Not Initiating IV Thrombolytic 
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Rationale:  This change is to clarify the abstraction guidelines for data elements that generate 
the majority of stroke abstraction questions and ease the burden of abstraction. 
Description of Changes: 
Definition 
Change to:  
Definition:  Reasons for not initiating IV thrombolytic.  
•  Documentation that intravenous (IV) or intra-arterial (IA) thrombolytic was initiated by a 
transferring hospital or emergency medical staff (EMS)  prior to hospital arrival 
•  Documentation of patient/family refusal of IV thrombolytic 
•  Documentation of a National Institutes for Health Stroke Scale (NIHSS) score of zero in 
the emergency department   
•  Documentation of cardiac arrest, respiratory arrest, cardiopulmonary resuscitation, 
defibrillation, or intubation in the emergency department 
•  Comfort Measures Only documented by a physician/APN/PA  
•  Other reasons for not initiating IV thrombolytics documented by physician/APN/PA or 
pharmacist 
 
Suggested Data Collection Question 
Change to: 
Is there documentation on the day of or day after hospital arrival of a reason for not initiating IV 
thrombolytic? 
 
Allowable Values 
Change from: 
Y (Yes)   There is physician/APN/PA or pharmacist documentation of a reason for not 
initiating IV thrombolytic.  
 
N (No)   There is no physician/APN/PA or pharmacist documentation of a reason for not 
initiating IV thrombolytic, OR unable to determine from the medical record 
documentation. 
To: 
Y (Yes)   There is documentation on the day of or the day after hospital arrival of a reason 
for not initiating IV thrombolytic.  
 
N (No)   There is no documentation on the day of or day after hospital arrival of a reason 
for not initiating IV thrombolytic, OR unable to determine from the medical record 
documentation. 
 
Notes for Abstraction 
Change to:  
•  Documentation of a reason for not initiating IV thrombolytic must be done on the 
day of or the day after hospital arrival.  It is not necessary to review 
documentation outside of this timeframe to answer this data element.   
•  “Other” reasons for not initiating IV thrombolytic therapy must be documented by a 
physician/APN/PA or pharmacist.  
EXCEPTION: 
Nursing documentation of a telemedicine/teleneurology reason for not initiating IV 
thrombolytic therapy is acceptable.   
Specifications Manual for Hospital Inpatient Quality Measures  Page 46 
Discharges 01-1-15 (1Q15) through 09-30-15 (3Q15) Release Notes Version 4.4 
•  The following are acceptable as stand-alone reasons for not initiating IV thrombolytics 
– IV thrombolytic therapy linkage is not needed: 
o  Documentation that intravenous (IV) or intra-arterial (IA) thrombolytic was 
initiated by a transferring hospital or EMS prior to hospital arrival 
o  Documentation of patient/family refusal of IV thrombolytic 
o  Documentation of NIHSS score of zero in the emergency department   
o  Documentation of cardiac arrest, respiratory arrest, cardiopulmonary 
resuscitation, defibrillation, or intubation in the emergency department 
o  Comfort Measures Only documented by a physician/APN/PA 
•  If  “other” reasons are not mentioned in the context of IV thrombolytics, do not 
make inferences (e.g., do not assume that IV thrombolytic was not initiated because of 
a bleeding disorder unless explicitly stated in the documentation).  
Acceptable examples (select “Yes”): 
o  “Frail 95 year old – will not give thrombolytics due to age” 
o  “Patient with Stage IV cancer – No t-PA” 
o  “Increased risk of bleeding – hold t-PA for further evaluation” 
•  Documentation by a physician/APN/PA or pharmacist that the patient is not a t-PA 
candidate, not eligible for IV thrombolytic therapy, thrombolytics are not indicated, or t-
PA is contraindicated, without mention of the underlying reason, is acceptable as an 
“other” reason if it is documented on the day of or day after hospital arrival.   
•  Documentation by a physician/APN/PA that the patient has no neurological deficits, 
e.g., “normal neuro exam,” “neurological exam has returned to baseline” at the time of 
presentation to the emergency department, is acceptable as an “other” reason if it is 
documented on the day of or day after hospital arrival.   
•  Reason documentation which refers to intravenous medications only (e.g., “Hold IV 
medications,” “No IVs”), is not acceptable. 
•  System reasons are not acceptable as “other” reasons, regardless of any linkage 
to IV thrombolytics: 
o  Equipment-related (e.g., CT not available, IV pump malfunction) 
o  Pharmacy-related (e.g., thrombolytic agent not available from pharmacy) 
o  Staff-related (e.g., unable to contact consulting MD) 
 
Suggested Data Sources 
Remove: 
ONLY PHYSICIAN/APN/PA OR PHARMACIST DOCUMENTATION OF A REASON FOR NOT 
INITIATING IV THROMBOLYTIC: 
Add: 
•  Medical transport records 
•  Nursing notes 
•  Physician orders 
•  Transfer forms 
 
Remove: 
Excluded Data Sources: 
Discharge summary 
 
Remove: 
Specifications Manual for Hospital Inpatient Quality Measures  Page 47 
Discharges 01-1-15 (1Q15) through 09-30-15 (3Q15) Release Notes Version 4.4 
ADDITIONAL SUGGESTED DATA SOURCES FOR PATIENT/FAMILY REFUSAL, NIHSS 
SCORE OF ZERO, AND INITIATION OF IV or IA THROMBOLYTIC AT A TRANSFERRING 
HOSPITAL ONLY:  
•  Medical transport records 
•  Nurses notes  
•  Transfer forms  
 
Inclusion Guidelines for Abstraction 
Change to: 
None 
 
Exclusion Guidelines for Abstraction 
Change to: 
•  Delay in stroke diagnosis 
•  Hold IV thrombolytic without a documented reason 
•  No IV access 
 
Impacts: 
Reason for Not Prescribing Statin Medication at Discharge 
Statin Medication Prescribed at Discharge 
Rationale:  These measures are being removed based on the FY 2014 IPPS Final Rule and at 
the direction of CMS. 
Description of Changes: 
Remove: 
The Joint Commission Only:  AMI-10; CMS Voluntary Only:  AMI-10 
 
I 
 
Impacts: 
Referral for Addictions Treatment 
Rationale:  Patients without a residence in the USA are not a part of the measure population, 
so only allowable value “4” should be selected. The referral can also be made by health care 
organization staff and can be completed at any time during the hospitalization prior to 
discharge. 
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Description of Changes: 
Allowable Values 
Change value 1 from: 
The referral to addictions treatment was made by the healthcare provider prior to discharge. 
To: 
The referral to addictions treatment was made by the healthcare provider or health care 
organization at any time prior to discharge. 
 
Change value 2 from: 
Referral information was given to the patient at discharge but the appointment was not made 
by the provider prior to discharge. 
To: 
Referral information was given to the patient at discharge but the appointment was not made 
by the provider or health care organization prior to discharge. 
 
Change value 4 from: 
The referral for addictions treatment was not offered because the patient’s residence is not in 
the USA. 
To: 
The patient’s residence is not in the USA. 
 
Notes for Abstraction 
Add new second bullet: 
•  If the patient does not have a residence in the USA, value “4” must be selected. 
 
Impacts: 
Referral for Outpatient Tobacco Cessation Counseling 
Rationale:  Patients without a residence in the USA are not a part of the measure population, 
so only allowable value “4” should be selected. The referral can also be made by health care 
organization staff and can be completed at any time during the hospitalization prior to 
discharge. 
Description of Changes: 
Allowable Values 
Change value 1 from: 
The referral to outpatient tobacco cessation counseling treatment was made by the healthcare 
provider or prior to discharge. 
To: 
The referral to outpatient tobacco cessation counseling treatment was made by the healthcare 
provider or health care organization at any time prior to discharge. 
 
Change value 2 from: 
Referral information was given to the patient at discharge but the appointment was not made 
by the provider prior to discharge. 
To: 
Referral information was given to the patient at discharge but the appointment was not made 
by the provider or health care organization prior to discharge. 
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Change value 4 from: 
The referral for outpatient tobacco cessation counseling treatment was not offered because the 
patient’s residence is not in the USA. 
To: 
The patient’s residence is not in the USA. 
 
Notes for Abstraction 
Add new fifth bullet: 
•  If the patient does not have a residence in the USA, value “4” must be selected. 
 
Impacts: 
Sex 
Rationale:  The verbiage used in the manual for data elements collected for all records is 
being updated. 
Description of Changes: 
Collected For 
Change to: 
CMS/The Joint Commission:  All Records  
Suggested Data Sources 
Change last bullet to: 
•  UB-04 
 
Impacts: 
Time Last Known Well 
Rationale:  This change is to clarify the abstraction guidelines for data elements that generate 
the majority of stroke abstraction questions and ease the burden of abstraction. 
Description of Changes: 
Notes for Abstraction 
Change to:  
•  For times that include “seconds,” remove the seconds and record the time as is.  
Example:  
15:00:35 would be recorded as 15:00 
•  If the time last known well is unable to be determined from medical record 
documentation, select “UTD.” 
EXCEPTION: 
If the only time last known well is documented as a time immediately before hospital 
arrival without a specific time range in minutes, e.g., “symptoms started just prior to ED 
arrival,” and no other documentation mentioning time last known well is available in the 
medical record, use the Arrival Time for Time Last Known Well. 
•  The medical record must be abstracted as documented (taken at “face value”). When 
the time documented is obviously in error (not a valid time) and no other 
documentation is found that provides this information, the abstractor should select 
“UTD.”  
Example:  
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Documentation indicates the time last known well was 3300. No other 
documentation in the medical record provides a valid time. Since the time last 
known well is outside of the range listed in the Allowable Values for “Hour,” it is 
not a valid time and the abstractor should select “UTD.” 
Note: Transmission of a case with an invalid time as described above will be rejected 
from the QIO Clinical Warehouse and the Joint Commission’s Data Warehouse. Use of 
“UTD” for Time Last Known Well allows the case to be accepted into the warehouse. 
•  If the time last known well is documented as a specific time and entered as Time Last 
Known Well on a “Code Stroke” form or stroke-specific electronic template, enter that 
time as the time last known well. Documentation of Time Last Known Well on a stroke-
specific form or template should be selected regardless of other times last known well 
documented elsewhere in the medical record.   
•  If the time last known well is documented as being a specific number of hours prior to 
arrival (e.g., felt left side go numb 2 hours ago) rather than a specific time, subtract that 
number from the time of ED arrival and enter that time as the time last known well. 
•  If the time last known well is noted to be a range of time prior to ED arrival (e.g., felt left 
side go numb 2-3 hours ago), assume the maximum time from the range (e.g., 3 
hours), and subtract that number of hours from the time of arrival to compute the time 
last known well. 
•  If both the time last known well and the time of symptom onset are documented, select 
the Time Last Known Well. 
Examples: 
o  H&P states, “Patient watching TV with family and complained of blurred vision in 
both eyes at 8:30 PM.” ED MD notes, “Patient normal at 8:30 PM.”  Time Last 
Known Well is 2030.    
o  “Patient was doing well at 4:30 PM – noticed difficulty speaking around 6 PM.” 
Time Last Known Well is 1630. 
o  Patient normal at 2200 before going to bed.  Awoke at 0200 with headache and 
took two aspirin before returning to sleep.  OK at 0700 and went to work.  Felt 
confused, unable to speak without slurring at 0800.  Time Last Known Well is 
0700. 
•  If the only time documented is time of symptom onset without mention of when the 
patient was last known well, use the time of symptom onset for time last known well.  
Example: 
“Sudden onset headache one hour before ED arrival,” documented by EDMD. 
Arrival time 19:24.  No other documentation referencing time last known well 
available in medical record.  Time Last Known Well 18:24.   
•  If there are multiple times of last known well documented in the absence of the Time 
Last Known Well explicitly documented on a “Code Stroke” form, use physician 
documentation first before other sources, e.g., nursing, EMS.   
Example: 
“Patient last seen normal this morning at 1000” per H&P.  ED nurse documented 
09:50 as time last well.  Time Last Known Well is 1000. 
•  If multiple times last known well are documented by different physicians or by the same 
provider, use the earliest time documented.  
•  If there is documentation of one or more episodes of stroke symptoms AND 
documentation of symptom resolution between episodes, use the time of the most 
recent (last) episode prior to arrival, regardless if all symptoms resolved prior to arrival. 
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Examples: 
o  “Patient reported right hand paresthesia two days ago that resolved 
spontaneously after a few minutes.  New onset of symptoms today around 0700 
involving right arm and right leg.” Time Last Known Well is 0700. 
o  “Wife states that he was having trouble with slurred speech and confusion 
yesterday.  Symptom free this morning. Return of symptoms with facial droop 
noted around noon.”  Time Last Known Well is 1200. 
o  “Wife noticed slurred speech at 8:30 last night.  Without symptoms early this 
morning.  Wife noticed slurred speech again at 0900 during breakfast 
conversation.”  Time Last Known Well is 0900.   
o  “Wife noticed slurred speech at 8:30 last night.  Symptom-free this morning. 
Came to ED to get checked out.” Time Last Known Well is 2030.   
 
Suggested Data Sources 
Add new bullet: 
•  Code Stroke form/template 
 
Inclusion Guidelines for Abstraction 
Change to: 
Signs and Symptoms of Stroke 
•  Sudden numbness or weakness of the face, arm or leg, especially on one side of the 
body 
•  Sudden confusion, trouble speaking or understanding 
•  Sudden trouble seeing in one or both eyes 
•  Sudden trouble walking, dizziness, loss of balance or coordination 
•  Sudden severe headache 
 
Impacts: 
Tobacco Use Status 
Rationale:  This change is to make the language consistent throughout the measure set. 
Description of Changes: 
Notes for Abstraction 
Change the 1st bullet to: 
•  If there is definitive documentation that the patient either currently uses tobacco products or 
is an ex-user that quit less than 30 days prior to admission, select the appropriate allowable 
value for the type of product used, regardless of whether or not there is conflicting 
documentation. 
 
Impacts: 
Tobacco Use Status 
Rationale:  The current measure specifications exclude patients with cognitive impairment 
from all of the TOB and SUB measures, if there is documentation of cognitive impairment for 
the entire hospitalization. Since the alcohol use screen and/or tobacco use screen must be 
completed within 3 days after admission, cognitive impairment will now be evaluated in the 
Alcohol Use Status and Tobacco Use Status data elements, and the data element Cognitive 
Impairment will be removed from all of the TOB and SUB measures. 
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Description of Changes: 
Format 
Change ‘Length’ from 2 to: 
 1 
Allowable Values 
Add new value: 
6  The patient was not screened for tobacco use during the first three days of admission 
because of cognitve impairment. 
Notes for Abstraction 
Change first bullet to: 
•  If there is definitive documentation that the patient either currently uses tobacco products 
or is an ex-user that quit less than 30 days prior to  admission, select the appropriate 
allowable value for the type of product used, regardless of whether or not there is 
conflicting documentation.  
 
Add new bullets and examples:   
•  Cognition refers to mental activities associated with thinking, learning, and memory. 
Cognitive impairment for the purposes of this measure set is related to documentation 
that the patient cannot be screened for tobacco use due to the impairment (e.g., 
comatose, obtunded, confused, memory loss) during the entire first three days of 
hospitalization. 
•  Cognitive impairment must be documented at all times during the first three days of the 
hospitalization in order to select value “6.”  If there is documentation in the medical record 
that a patient is cognitively impaired, and there is no additional documentation that the 
patient’s mental status was normal at any other time during the first three days of the 
hospitalization, i.e., alert and oriented, the abstractor can select value “6”. 
•  If there is documentation that the patient has temporary cognitive impairment due to acute 
substance use (e.g., overdose or acute intoxication) value “6” cannot be selected. 
Examples of cognitive impairment include: 
o  Altered Level of Consciousness (LOC) 
o  Altered Mental Status 
o  Cognitive impairment 
o  Cognitively impaired 
o  Confused 
o  Memory loss 
o  Mentally retarded 
o  Obtunded 
 
Impacts: 
Tobacco Use Treatment FDA - Approved Cessation Medication 
Rationale:  This change is to make the language consistent throughout the measure set. 
Description of Changes: 
Exclusion Guidelines for Abstraction: 
Change 2nd bullet to: 
•  Light smokers (4 or less cigarettes per day) 
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Impacts:   
Transfer From Another Hospital or ASC 
Rationale:  The PN-3a and PN-3b measures are being removed at the direction of CMS and 
based on the IPPS Fiscal Year 2014 Final Rule. 
Description of Changes: 
Collected For 
Remove under ‘The Joint Commission Only’:  
PN-3a 
Remove under ‘CMS Voluntary Only’:   
PN-3a 
 
Impacts: 
Urinary Catheter 
Rationale:  This change is to provide additional abstraction instructions. 
Description of Changes: 
Notes for Abstraction 
Add seventh bullet: 
•  If a urinary catheter is used to monitor intra-abdominal pressure on POD 0, 1, or 2, 
select value “No.” 
 
Impacts: 
Vancomycin 
Rationale:  Documentation is being added to define the preoperative period for the data 
element. 
Description of Changes: 
Notes for Abstraction 
Change second bullet: 
•  Physician/APN/PA, pharmacist or infection control practitioner documentation of the reason 
for the use of vancomycin as prophylaxis must have been entered into the medical record 
prior to the incision time to select values “5,” “6,” “8,” and “10.” If the documentation was not 
entered  prior to the incision time, select value “9”- No documented reason/Unable to 
Determine. 
 
Impacts: 
VTE Confirmed 
Rationale:  The Technical Advisory Panel reviewed clinical scenarios presented and 
determined that a timeframe was needed for documentation to be acceptable for these data 
elements. An additional data element was added to further define reasons for not providing 
prophylaxis to records in VTE-6 Hospital Acquired VTE. 
Description of Changes: 
Definition 
Change to: 
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Documentation by a physician/APN/PA that a diagnosis of VTE [deep vein thrombosis (DVT) 
and/or pulmonary embolism (PE)] was confirmed in a defined location within four days prior to 
arrival, or anytime during the hospitalization. 
 
Suggested Data Collection Question 
Change to: 
Is there physician/APN/PA documentation that the patient had a VTE Diagnostic Test and a 
VTE was confirmed in one of the defined locations within four days prior to arrival, or anytime 
during the hospitalization? 
 
Allowable Values 
Change from: 
Y (Yes)   There is documentation that the patient had a diagnosis of VTE confirmed in one 
of the defined locations. 
 
N (No)  There is no documentation that the patient had a diagnosis of VTE confirmed in 
one of the defined locations or unable to determine from medical record 
documentation.  
To: 
Y (Yes)   There is physician/APN/PA documentation that the patient had a VTE Diagnostic 
Test and VTE was confirmed in one of the defined locations within four days prior 
to arrival or anytime during the hospitalization. 
 
N (No)  There is no physician/APN/PA documentation that the patient had a VTE 
Diagnostic Test and VTE was confirmed in one of the defined locations within 
four days of arrival or anytime during the hospitalization, or unable to determine 
from medical record documentation.  
 
Notes for Abstraction 
Change to: 
•  This data element includes patients who had an acceptable VTE Diagnostic Test and 
are confirmed to have an acute VTE by a physician/APN/PA within four days prior to 
arrival or anytime during the hospitalization. Refer to the data element VTE Diagnostic 
Test for a list of acceptable tests.  
Examples: 
o  Physician/APN/PA documentation states that PE was confirmed with a VQ scan 
on arrival in the emergency department, select “Yes.” 
o  Physician/ APN/PA documentation states that the patient may have arrived 
without prior DVT confirmation, but after arrival, there is documentation based on 
a venous Doppler that the patient developed an acute DVT.  
o  Physician/APN/PA documentation states that the patient had an acceptable VTE 
Diagnostic Test which confirmed the development of the VTE anytime during the 
hospital stay. 
•  If a patient had a new or acute VTE confirmed in one of the defined locations by an 
acceptable VTE Diagnostic Test within four days prior to arrival or anytime during the 
hospitalization, select “Yes.” 
Examples: 
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o  Patient arrives as a direct admission on 01/03/20XX with documentation of a 
pulmonary emboli confirmed in the right upper lobe by VQ scan, dated 
01/01/20XX from an outside facility, select “Yes.” 
o  Patient arrives to the emergency department on 01/03/20XX with outside 
documentation of a DVT in the right femoral vein and no date is noted, select 
“No.” 
o  Patient arrives to the emergency department on 05/01/20XX and past medical 
history reveals a DVT confirmed in the right superficial distal vein from 
1/01/20XX, greater than four calendar days prior to arrival, select “No.”  
•  If the patient was transferred from another acute care hospital with a VTE, and there is 
no documentation indicating the VTE location, select “No.”  
•  Recurrent, chronic, sub-acute, or history of VTE is acceptable ONLY if there is 
documentation of an acute or new VTE.  
Example: 
If a patient had a history of lower extremity DVT, but vascular ultrasound found a 
new DVT in the proximal vein of the right lower extremity, select “Yes.”  
•  If more than one acceptable VTE Diagnostic Test was performed, review the chart for 
the earliest acceptable VTE Diagnostic Test that confirmed the VTE in one of the 
defined locations. 
Example: 
Patient had CT of chest with contrast in the emergency department on arrival on 
02/01/20xx for shortness of breath, no PE confirmed.  The patient was admitted, 
then on 02/03/20XX patient had venous ultrasound with confirmed proximal left 
lower extremity DVT. Select “Yes.” 
•  For patients with “low probability” or “inconclusive test results” on any of the acceptable 
VTE Diagnostic Tests, select “No.” 
•  For patients with a nuclear medicine VQ scan to rule-out PE; if the result was 
documented as “high probability,” select “Yes.” For all other impressions (e.g., “low 
probability,” “intermediate,” “intermediate to high probability” or “inconclusive test 
results”), select “No.” 
•  If there is questionable physician/APN/PA documentation regarding whether the patient 
had VTE, select “Yes.”  
Example: 
If the radiologist interpretation of the exam did not confirm DVT, but there is 
documentation of a DVT in physician’s progress notes, select “Yes.” 
•  If the record indicates ONLY a radiology report, and that report is questionable 
regarding whether the patient had a VTE, select “No.” 
Examples: 
o  If the radiology report of a CTA indicates, “possible” or “suggestive of” common 
femoral clot, select “No”.  
o  If the radiology report of an angiogram indicates, distal vein clot that may extend 
into the greater saphenous vein, select “No.” 
 
Documentation in sources other than radiology reports: 
•  The physician/APN/PA documentation must reflect the time frame within four calendar 
days prior to arrival or anytime during hospitalization. 
•  The physician/APN/PA documentation must indicate the clinician’s confirmation of an 
acute VTE. 
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  Example: 
Physician Notes: Venous Doppler on day of admission positive for DVT left 
popliteal vein clot, select “Yes.” 
Inclusion Guidelines for Abstraction 
VTE Location 
Change to:   
VTE Confirmed is defined as: 
•  DVT located in the proximal leg veins, including superficial femoral vein 
•  DVT located in the inferior vena cava (IVC) 
•  DVT located in the iliac, femoral or popliteal veins 
•  Pulmonary Emboli (PE) 
 
Exclusion Guidelines for Abstraction 
Change first and second bullet: 
•  Confirmed sites of venous thrombosis without a proximal leg DVT or PE also involved.  
•  History of VTE greater than four days prior to arrival, without documentation of a 
new/acute event. 
 
Impacts: 
VTE Diagnostic Test 
Rationale:  The Technical Advisory Panel reviewed clinical scenarios presented and 
determined that a timeframe was needed for documentation to be acceptable for these data 
elements. An additional data element was added to further define reasons for not providing 
prophylaxis to records in VTE-6 Hospital Acquired VTE. 
Description of Changes: 
Definition 
Change to: 
Documentation that a diagnostic test was performed within four days prior to arrival or anytime 
during the hospitalization. 
 
Suggested Data Collection Question 
Change to: 
Is there documentation that a diagnostic test was performed within four days prior to arrival or 
anytime during the hospitalization? 
 
Allowable Values 
Change from: 
Y (Yes)  There is documentation that a diagnostic test for VTE was performed. 
 
N (No)  There is no documentation that a diagnostic test for VTE was performed or 
unable to determine from medical record documentation.  
To: 
Y (Yes)  There is documentation that a diagnostic test was performed within four days 
prior to arrival or anytime during the hospitalization. 
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N (No)  There is no documentation that a diagnostic test was performed within four 
days prior to arrival, or anytime during the hospitalization, or unable to 
determine from medical record documentation.  
 
Notes for Abstraction 
Change to: 
•  This data element includes patients who had one of the acceptable diagnostic tests 
performed within four days prior to arrival or anytime during hospitalization.  
Examples: 
o  Patient arrives on 01/01/20XX and documentation indicates a CT of chest with 
contrast was performed on arrival, earlier that same day. 
o  Patient arrived on 01/01/20XX and documentation indicates that the patient was 
admitted on 01/02/20XX. A VQ scan was performed on 01/02/20XX. 
o  Patient transferred on 01/05/20XX with documentation from a transferring 
hospital indicating vascular ultrasound was performed on 01/02/20XX.” 
•  If a diagnostic test was performed that is not on the inclusion list, select “No.”  
Example: 
Physician notes indicate a 2D Echo was done that confirmed a PE, select “No.” 
 
Documentation in sources other than radiology reports: 
•  Documentation other than radiology reports must confirm one of the acceptable tests 
was performed.  
Examples: 
o  Physician Notes: Venous doppler positive for DVT left popliteal, select “Yes.” 
o  Emergency Notes: Patient to CT without contrast, select “No.” 
•  The physician/APN//PA documentation must reflect the time frame within four calendar 
days prior to arrival or anytime during hospitalization. 
Suggested Data Sources 
Remove:   
•  Nursing Notes 
 
Inclusion Guidelines for Abstraction 
Change to: 
•  Compression Ultrasound of lower extremitites 
•  Vascular Ultrasound of lower extremitites 
•  Duplex Ultrasound (DUS) of lower extremtites 
•  Venous Doppler of lower extremities 
•  Computed tomography (CT) of thorax (chest) with contrast 
•  Computed tomography (CT) of the abdomen with contrast 
•  Computed tomography (CT) of the pelvis with contrast 
•  Computed tomography (CT) of the lower extremity leg veins with contrast  
•  Magnetic resonance imaging (MRI or MRV) of the thorax (chest) 
•  Magnetic resonance imaging (MRI or MRV) of the abdomen 
•  Magnetic resonance imaging (MRI or MRV) of the pelvis 
•  Magnetic resonance imaging (MRI or MRV) of the lower extremity leg veins 
•  Nuclear Medicine Pulmonary Scan/ventilation/perfusion (V/Q) lung scan 
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•  Pulmonary arteriography/angiography/angiogram 
•  Venography/Venogram of pelvis using contrast material 
•  Venography/Venogram of femoral using contrast material 
•  Venography/ Venogram of other lower extremity veins using contrast material 
 
Exclusion Guidelines for Abstraction 
Add bullet: 
•  Patients with a diagnostic test performed greater than four days prior to arrival. 
 
Impacts: 
VTE Present at Admission 
Rationale:  The Technical Advisory Panel reviewed clinical scenarios presented and 
determined that a timeframe was needed for documentation to be acceptable for these data 
elements. An additional data element was added to further define reasons for not providing 
prophylaxis to records in VTE-6 Hospital Acquired VTE. 
Description of Changes: 
Definition 
Change to: 
Documentation by a physician/APN/PA that VTE was diagnosed or suspected on arrival to the 
day after admission. 
 
Suggested Data Collection Question 
Change to: 
Was there any documentation by the physician/APN/PA that VTE was diagnosed or suspected 
on arrival to the day after admission? 
 
Allowable Values 
Change from: 
Y (Yes)  There is documentation by the physician/APN/PA that VTE was diagnosed or 
suspected on admission. 
 
N (No)  There is no documentation by the physician/APN/PA that VTE was diagnosed or 
suspected on admission or unable to determine from medical record 
documentation. 
To: 
Y (Yes)  There is documentation by the physician/APN/PA that VTE was diagnosed or 
suspected on arrival to the day after admission. 
 
N (No)  There is no documentation by the physician/APN/PA that VTE was diagnosed or 
suspected on arrival or the day after admission, or unable to determine from 
medical record documentation. 
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Notes for Abstraction 
Change to: 
•  The time frame for this data element includes any documentation of VTE confirmed or 
suspected from arrival to the day after admission. Documentation of a VTE Diagnostic 
Test, diagnosis or suspicion of VTE is acceptable.  
Example:  
A patient arrived on 10/1/20xx with shortness of breath. On 10/2/20XX, there is 
documentation that a pulmonary emboli (PE) was suspected, select “Yes.” 
•  If documentation is questionable regarding whether VTE was present or suspected at 
admission, select “Yes.”  
•  For patients with only a history of VTE documented, select “No.” 
•  If the patient was admitted and had surgery on day of or day after hospital admission or 
ICU admission and there was no documentation of diagnosed/suspected VTE prior to 
surgery, the VTE is not considered present on admission. Select “No.” 
 
Inclusion Guidelines for Abstraction 
Change to: 
None 
 
Impacts: 
VTE Prophylaxis 
Rationale:  The need for clarification of documentation that is acceptable for these data 
elements was identified through review of clinical scenarios by the Technical Advisory Panel.   
Description of Changes: 
Notes for Abstraction 
ALL 
Change example to: 
Lovenox is ordered and substituted with dalteparin. Only abstract value "2" once, as 
both are LMWH. 
VTE 
Change to: 
Abstract ALL VTE prophylaxis(s) that was administered the day of or the day after hospital 
admission or the day of or the day after Surgery End Date for surgeries that start the day of or 
the day after hospital admission. If no VTE prophylaxis was administered during this 
timeframe, select “A.”  
 
STK 
Change to: 
Abstract ALL VTE prophylaxis(s) that was administered the day of or the day after hospital 
admission. If no VTE prophylaxis was administered during this timeframe, select “A.”  
VTE or STK 
Change first bullet to: 
•  Selection of allowable values 1-9 includes any prophylaxis that was administered in the 
allowable time frame. 
Example:  
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If a patient was admitted on 12/8/20xx and had bilateral GCS applied at 13:00 on 
12/09/20xx and LMWH was administered at 22:00 on 12/8/20xx, select values “2” 
and “4.” 
 
Change example in third bullet to: 
Lovenox is ordered, but not received and is substituted with fondaparinux sodium, which is 
received by the patient. Abstract fondaparinux sodium as value “5” for VTE Prophylaxis and 
abstract the date it was administered for VTE Prophylaxis Date.  
Remove fourth bullet: 
•  Aspirin is not an approved medication for prophylaxis in the VTE and STK population.  If 
aspirin is the only source of prophylaxis found in the record, select “A,” and check for a 
Reason for No VTE Prophylaxis. 
 
Impacts: 
VTE Prophylaxis Date 
Rationale:  The need for clarification of documentation that is acceptable for these data 
elements was identified through review of clinical scenarios by the Technical Advisory Panel.   
Description of Changes: 
Definition 
Remove the words “the initial” 
 
Suggested Data Collection Question 
Remove the word “initial” 
 
Notes for Abstraction 
Add: 
STK 
The earliest date associated with a form of prophylaxis other than GCS or aspirin should be 
entered.  
Example:  
If the patient was admitted on 12/8/20xx and bilateral GCS was applied at 13:00 on 
12/8/20xx and LMWH was administered at 02:00 on 12/9/20xx, record the 12/9/20xx 
date.  
 
VTE 
The earliest date associated with a form of prophylaxis other than aspirin should be used 
entered. 
Example:  
If the patient was admitted on 12/8/20xx and aspirin was administered at 13:00 on 
12/8/20xx and LMWH was administered at 02:00 on 12/9/20xx, record the 12/9/20xx date.  
 
Suggested Data Sources 
Change to: 
•  Circulator’s notes  
•  Graphic/flow sheets  
•  Medication administration record  
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•  Nursing notes  
•  Operative notes  
•  Physician notes  
•  Preoperative nursing notes  
•  Progress notes 
 
Impacts: 
VTE Prophylaxis Status 
Rationale:  The Technical Advisory Panel reviewed clinical scenarios presented and 
determined that a timeframe was needed for documentation to be acceptable for these data 
elements. An additional data element was added to further define reasons for not providing 
prophylaxis to records in VTE 6 Hospital Acquired VTE. 
Description of Changes: 
Definition 
Change to: 
Documentation of VTE prophylaxis (mechanical or pharmacologic) administration between the 
hospital admission date and VTE Diagnostic Test order date.  
 
Suggested Data Collection Question 
Change to: 
Was VTE prophylaxis administered between the admission date and the VTE Diagnostic Test 
order date? 
 
Allowable Values 
Change from: 
1   There is documentation that VTE prophylaxis was administered between the day of 
admission and the day before the VTE diagnostic test order date. 
 
2  There is no documentation that VTE prophylaxis was administered between the day of 
admission and the day before the VTE diagnostic test order date or unable to 
determine from medical record documentation. 
 
3  There is physician/advanced practice nurse/physician assistant (physician/APN/PA) or 
pharmacist documentation of a reason for not administering mechanical and 
pharmacological VTE prophylaxis during hospitalization.  
To: 
Y (Yes)   There is documentation that VTE prophylaxis was administered between the day 
  of admission and the VTE Diagnostic Test order date. 
 
N (No)  There is no documentation that VTE prophylaxis was administered between the 
  day of admission and the VTE Diagnostic Test order date or unable to determine 
  from medical record documentation. 
 
Notes for Abstraction 
Change to: 
•  To determine the value for this data element, the abstractor must determine the 
admission date and review the chart to ascertain if VTE prophylaxis was administered 
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before the VTE Diagnostic Test order date. Refer to the data element VTE Diagnostic 
Test for a list of acceptable tests. If any VTE prophylaxis was administered within the 
specified timeframe above, select “Yes.” 
•  If more than one acceptable VTE Diagnostic Test was ordered to rule out VTE and both 
confirmed VTE, select the earliest diagnostic test ordered that confirmed VTE to 
determine if the patient received VTE prophylaxis.  
Example:  
Patient was admitted on 11/1/20XX. A venous doppler of lower extremities was 
ordered 11/4/20xx and confirmed a DVT of the right lower extremity. In addition, a 
CT scan with contrast was ordered on 11/5/20xx and confirmed a PE. Determine 
if any prophylaxis was administered any time between the hospital admission 
date of 11/1/20XX and 11/4/20xx. If no prophylaxis was given, select “No.” 
•  If the VTE Diagnostic Test was ordered the day of or the day after the admission date, 
select “Yes.”  
•  If the record contains questionable information regarding the administration of VTE 
prophylaxis prior to the VTE Diagnostic Test was ordered, select “No.” 
•  Application of mechanical prophylaxis may be documented by any personnel. 
Example:  
Nursing assistant documentation of IPC application during the allowable 
timeframe is acceptable.  
•  Evaluate prophylaxis with documentation of administration only.  
Example: 
The only documentation of prophylaxis is in the physician progress notes under 
assessment/Plan: “DVT prophylaxis – IPC,” select “No” because there is no 
documentation of administration. 
•  If one pharmacological medication is ordered and another medication is substituted 
(such as per pharmacy formulary substitution or protocol), select “Yes” if the substitution 
medication was administered.  
Note: No copy of the formulary or protocol is required in the medical record.  
Example: 
Lovenox is ordered but not administered, and is substituted with Arixtra, which is 
administered. Select “Yes.” 
•  Aspirin is not an approved medication for prophylaxis in the VTE population. If aspirin is 
the only form of prophylaxis documented in the record, select “No.” 
 
Suggested Data Sources 
Change to:   
•  Circulator notes  
•  Emergency department record  
•  Graphic/flow sheets  
•  Medication administration record  
•  Nursing notes  
•  Operative notes  
•  Physician notes  
•  Preoperative nursing notes  
•  Progress notes  
•  Radiology reports 
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Remove: 
Allowable Values 1 or 2: 
•  Consultation notes 
•  Discharge summary  
•  Emergency department record 
•  Medication administration record  
•  Nursing notes 
•  Progress notes 
 
Allowable Value 3: 
ONLY PHYSICIAN/APN/PA OR PHARMACIST DOCUMENTATION OF A REASON FOR 
NOT ADMINISTERING BOTH MECHANICAL AND PHARMACOLOGIC VTE PROPHYLAXIS  
•  Anesthesia record 
•  Consultation notes 
•  Discharge summary 
•  History and physical 
•  Physician orders 
•  Physician progress notes 
 
SUGGESTED DATA SOURCES FOR PATIENT REFUSAL (other than physician/APN/PA or 
pharmacist documentation of a reason for not administering any type of VTE prophylaxis as 
above): 
•  Medication administration record  
•  Nurses notes 
 
Inclusion Guidelines for Abstraction 
Change to: 
A list of the ONLY acceptable diagnostic tests is found in the data element VTE Diagnostic 
Test. 
 
Exclusion Guidelines for Abstraction 
Change to: 
None 
 
Impacts: 
Warfarin Administration 
Rationale:  Clinical scenarios presented to the Technical Advisory Panel (TAP) justified the 
need for defined time frames, and the need for examples and clarifications to capture 
acceptable documentation for these data elements. 
Description of Changes: 
Definition 
Change to: 
Documentation that warfarin was administered any time after the VTE Diagnostic Test. 
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Suggested Data Collection Question 
Change to: 
Was warfarin administered any time after the VTE Diagnostic Test? 
 
Allowable Values 
Change from: 
Y (Yes)  There is documentation that warfarin was administered during hospitalization.  
 
N (No)  There is no documentation that warfarin was administered during hospitalization 
or unable to determine from the medical record documentation. 
To: 
Y (Yes)  There is documentation that warfarin was administered any time after the VTE 
Diagnostic Test.  
 
N (No)  There is no documentation that warfarin was administered any time after the 
VTE Diagnostic Test, or unable to determine from the medical record 
documentation. 
 
Notes for Abstraction 
Change to: 
•  To determine the value for this data element, the abstractor must locate the acceptable 
VTE Diagnostic Test completed, and then review the chart to ascertain if warfarin was 
administered any time after the test. If warfarin was administered, select “Yes.”  Refer to 
the data element VTE Diagnostic Test for a list of acceptable tests.  
•  If warfarin was ordered, but not administered, select “No.” 
•  If VTE was diagnosed prior to admission and warfarin was administered on arrival, 
select “Yes.” 
•  If the VTE Diagnostic Test and warfarin administration are on the same day, or any time 
thereafter select “Yes.” 
 
Exclusion Guidelines for Abstraction 
Change to: 
Warfarin administered prior to day of arrival. 
 
SECTION 2 – Measurement Information 
Impacts:   
Algorithms 
Measure(s) 
CAC-1 
CAC-2 
ED-1 
ED-2 
IMM-1 
SCIP-Inf-1 
SCIP-Inf-2 
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SCIP-Inf-3 
SUB-2 
SUB-3 
TOB-2 
TOB-3 
Rationale:  This change will provide consistency in algorithm stratification across measure 
sets. 
Description of Changes: 
SCIP-Inf-1, SCIP-Inf-2, SCIP-Inf-3, ED-1, ED-2, CAC-1, CAC-2, SUB-2, SUB-3, TOB-2, TOB-3 
Change: 
Corresponding stratum to X when the overall measure category assignment is X.  
 
IMM-1 
Change: Overall measure category assignment X goes directly to Stop and does not go 
through stratification.   
 
ED-1, ED-2 
Remove: UTD Counter and all associated logic. 
Remove: Variable Key box. 
Remove: Both Note Boxes near the “B” measure category assignment boxes. 
Remove: The “B” measure category assignment box after the “X” measure category 
assignment box. 
Add: Overall Rate Category Assignment decision box on Strata page before the ICD-9-CM 
Principal Diagnosis Code decision box. 
 
Subsection 2.1 – Acute Myocardial Infarction (AMI) 
Impacts:  
Measure(s) 
AMI-2 
AMI-10 
Rationale:  These measures are being removed based on the FY 2014 IPPS Final Rule and at 
the direction of CMS. 
Description of Changes: 
ACUTE MYOCARDIAL INFARCTION NATIONAL HOSPITAL INPATIENT QUALITY 
MEASURES Table 
Remove under ‘Set Measure ID #’ column: 
AMI-2 
AMI-10 
 
Remove under ‘Measure Short Name’ column: 
Aspirin Prescribed at Discharge 
Statin Prescribed at Discharge 
 
AMI DATA ELEMENT LIST 
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Remove rows: 
Aspirin Prescribed at Discharge 
LDL-c Less Than 100 mg/dL 
Reason for No Aspirin at Discharge 
Reason for Not Prescribing Statin Medication at Discharge 
Statin Medication Prescribed at Discharge 
 
Change in the ‘Collected For’ column for Clinical Trial to: 
All AMI Measures 
 
Remove in the ‘Collected For’ column for Comfort Measures Only: 
AMI-2 
AMI-10 
 
Remove in the ‘Collected For’ column for Discharge Disposition: 
AMI-2 
AMI-10 
 
Remove the following Measure Information Forms in their entirety: 
AMI-2: Aspirin Prescribed at Discharge 
AMI-10: Statin Prescribed at Discharge 
 
Impacts:   
AMI Data Element List 
Rationale:  This change is to remove the reference to algorithms in general data elements to 
correct inconsistencies in data elements collected for all records. Measure algorithm 
information is identified in the XML file layout document. 
Description of Changes: 
Discharge Date 
Remove under ‘Collected For’ column: 
(Used in Algorithm for AMI-1) 
ICD-9-CM Other Procedure Codes  
ICD-9-CM Principal Procedure Code 
Remove under ‘Collected For’ column: 
(Used in Algorithm for AMI-8, AMI-8a) 
 
Impacts: 
Measure(s) 
AMI-7 
Rationale:  The latest ACCF/AHA STEMI clinical guidelines no longer support taking LBBB on 
the presenting ECG as a criterion for candidacy for acute reperfusion. 
Description of Changes: 
Description 
Change to: 
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Median time from arrival to administration of fibrinolytic therapy in acute myocardial infarction 
(AMI) patients with ST-segment elevation on the electrocardiogram (ECG) performed closest 
to hospital arrival time. 
 
Continuous Variable Statement 
Change to: 
Time (in minutes) from hospital arrival to administration of fibrinolytic therapy in patients with 
ST-segment elevation on the ECG performed closest to hospital arrival. 
 
Included Populations 
Change second bullet to: 
•  ST-segment elevation on the ECG performed closest to hospital arrival 
 
Impacts: 
Algorithms 
Measure(s) 
AMI-7 
AMI-7a 
AMI-8 
AMI-8a 
Rationale:  The latest ACCF/AHA STEMI clinical guidelines no longer support taking LBBB on 
the presenting ECG as a criterion for candidacy for acute reperfusion. 
Description of Changes: 
AMI-7 
AMI-8 
Remove: “Or LBBB” from the Continuous Variable Statement. 
 
AMI-7a 
AMI-8a  
Remove: “Or LBBB” from the Denominator statement. 
 
 
Impacts: 
Measure(s) 
AMI-7a 
Rationale:  The latest ACCF/AHA STEMI clinical guidelines no longer support taking LBBB on 
the presenting ECG as a criterion for candidacy for acute reperfusion. 
Description of Changes: 
Description 
Change to: 
Acute myocardial infarction (AMI) patients with ST-segment elevation on the ECG closest to 
arrival time receiving fibrinolytic therapy during the hospital stay and having a time from 
hospital arrival to fibrinolysis of 30 minutes or less. 
 
Denominator Statement 
Change to: 
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AMI patients with ST-elevation on ECG who received fibrinolytic therapy. 
 
Included Populations 
Change second bullet to: 
•  ST-segment elevation on the ECG performed closest to hospital arrival 
 
Impacts: 
Measure(s) 
AMI-7a 
Rationale:  The Measure analysis section needed to be updated to reflect that this is 
suggested analysis and not mandatory. 
Description of Changes: 
Measure Analysis Suggestions 
Change to: 
The measure rate for fibrinolytic agent received within 30 minutes of hospital arrival may be 
analyzed in conjunction with the median time to fibrinolysis measure (AMI-7). These measures, 
used together, can assist in understanding the number of AMI patients that are receiving 
fibrinolysis within 30 minutes of hospital arrival and can identify the hospital’s median time to 
fibrinolysis and potential opportunities for improvement to increase the rate of patients 
receiving fibrinolysis in 30 minutes or less. 
 
Impacts: 
Measure(s) 
AMI-8 
Rationale:  The latest ACCF/AHA STEMI clinical guidelines no longer support taking LBBB on 
the presenting ECG as a criterion for candidacy for acute reperfusion. 
Description of Changes: 
Description 
Change to: 
Median time from hospital arrival to primary percutaneous coronary intervention (PCI) in acute 
myocardial infarction (AMI) patients with ST-segment elevation on the electrocardiogram 
(ECG) performed closest to hospital arrival time. 
 
Continuous Variable Statement 
Change to: 
Time (in minutes) from hospital arrival to primary PCI in patients with ST-segment elevation on 
the ECG performed closest to hospital arrival. 
 
Included Populations 
Change third bullet to: 
•  ST-segment elevation on the ECG performed closest to hospital arrival 
 
Impacts: 
Measure(s) 
AMI-8 
AMI-8a 
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Rationale:  This change updates the Selected References and Rationale with the latest 
ACCF/AHA heart failure clinical guidelines. 
Description of Changes: 
Rationale 
Change reference in third sentence to: 
(O’Gara, 2013 and Levine, 2011) 
 
Selected References 
Change fourth bullet to: 
Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, et al. 2011 
ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American 
College of Cardiology Foundation/American Heart Association Task Force on Practice 
Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll 
Cardiol. 2011;58:e44–122. 
 
Impacts: 
Measure(s) 
AMI-8a 
Rationale:  The Measure analysis section needed to be updated to reflect that this is 
suggested analysis and not mandatory. 
Description of Changes: 
Measure Analysis Suggestions 
Change to: 
The measure rate for primary PCI received within 90 minutes of hospital arrival may be 
analyzed in conjunction with the median time to primary PCI measure (AMI-8). These 
measures, used together, can assist in understanding the number of AMI patients that are 
receiving primary PCI within 90 minutes of hospital arrival, and can identify the hospital’s 
median time to primary PCI and potential opportunities for improvement to increase the rate of 
patients receiving primary PCI in 90 minutes or less. 
 
Impacts: 
Measure(s) 
AMI-8a 
Rationale:  The latest ACCF/AHA STEMI clinical guidelines no longer support taking LBBB on 
the presenting ECG as a criterion for candidacy for acute reperfusion. 
Description of Changes: 
Description 
Change to: 
Acute myocardial infarction (AMI) patients with ST-segment elevation on the ECG closest to 
arrival time receiving primary PCI during the hospital stay with a time from hospital arrival to 
PCI of 90 minutes or less. 
 
Denominator Statement 
Change to: 
AMI patients with ST-elevation on ECG who received primary PCI. 
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Included Populations 
Change third bullet to: 
•  ST-segment elevation on the ECG performed closest to hospital arrival 
 
Subsection 2.2 – Heart Failure (HF) 
Impacts:   
HF Data Element List 
Rationale:  This change is to remove the reference to algorithms in general data elements to 
correct inconsistencies in data elements collected for all records. Measure algorithm 
information is identified in the XML file layout document. 
Description of Changes: 
ICD-9-CM Other Procedure Codes 
ICD-9-CM Principal Procedure Code 
Remove under ‘Collected For’ column: 
(Used in Algorithm for All HF Measures) 
 
Impacts: 
Measure(s) 
HF-1 
HF-3 
Rationale:  These measures are being removed based on the FY 2014 IPPS Final Rule and at 
the direction of CMS. 
Description of Changes: 
HEART FAILURE NATIONAL HOSPITAL INPATIENT QUALITY MEASURES Table 
Remove under ‘Set Measure ID #’ column: 
HF-1 
HF-3 
 
Remove under ‘Measure Short Name’ column: 
Discharge Instructions 
ACEI or ARB for LVSD 
 
 
AMI DATA ELEMENT LIST 
Remove rows: 
ACEI Prescribed at Discharge 
ARB Prescribed at Discharge 
Discharge Instructions Address Activity 
Discharge Instructions Address Diet 
Discharge Instructions Address Follow-up 
Discharge Instructions Address Medications 
Discharge Instructions Address Symptoms Worsening 
Discharge Instructions Address Weight Monitoring 
LVSD 
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Reason for No ACEI and No ARB at Discharge 
 
Change in the ‘Collected For’ column for Clinical Trial to: 
HF-2 
 
Change in the ‘Collected For’ column for Comfort Measures Only to: 
HF-2 
 
Change in the ‘Collected For’ column for Discharge Disposition to: 
HF-2 
 
Remove the following Measure Information Forms in their entirety: 
HF-1: Discharge Instructions 
HF-3: ACEI or ARB for LVSD 
 
Impacts: 
Measure(s) 
HF-2 
Rationale:  This change updates the Selected References and Rationale with the latest 
ACCF/AHA heart failure clinical guidelines. 
Description of Changes: 
Rationale 
Change reference in second sentence to: 
(Yancy, 2013 and HFSA, 2010). 
 
Selected References 
Remove second bullet: 
•  Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG, et al, 
writing on behalf of the 2005 Guideline Update for the Diagnosis and Management of 
Chronic Heart Failure in the Adult Writing Committee. 2009 focused update: ACCF/AHA 
guidelines for the diagnosis and management of heart failure in adults: a report of the 
American College of Cardiology/American Heart Association Task Force on Practice 
Guidelines. J Am Coll Cardiol. 2009;53:1343– 82. 
 
Add new bullet: 
•  Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, et al. 2013 
ACCF/AHA guideline for the management of heart failure: executive summary: a report of 
the American College of Cardiology Foundation/American Heart Association Task Force on 
Practice Guidelines. J Am Coll Cardiol 2013;62:1495–539. 
 
Subsection 2.3 – Pneumonia (PN) 
Impacts:  
PN Data Element List 
Another Source of Infection 
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Antibiotic Administration Date 
Antibiotic Administration Route 
Antibiotic Administration Time 
Antibiotic Allergy 
Antibiotic Name 
Antibiotic Received 
Blood Culture Collected 
Discharge Disposition 
ICU Admission or Transfer 
Initial Blood Culture Collection Date 
Initial Blood Culture Collection Time 
Reason for alternative Empiric antibiotic Therapy 
Transfer from Another Hospital or ASC 
Rationale:  The PN-3a and PN-3b measures are being removed at the direction of CMS and 
based on the IPPS Fiscal Year 2014 Final Rule. 
Description of Changes: 
Collected For 
Change to: 
All PN Measures 
 
Remove: 
Blood Culture Collected 
Discharge Disposition 
Initial Blood Culture Collection Date 
Initial Blood Culture Collection Time 
 
Impacts:   
PN Data Element List 
Rationale:  This change is to remove the reference to algorithms in general data elements to 
correct inconsistencies in data elements collected for all records. Measure algorithm 
information is identified in the XML file layout document. 
Description of Changes: 
Discharge Date 
ICD-9-CM Other Diagnosis Codes 
Remove under ‘Collected For’ column: 
(Used in Algorithm for All PN Measures) 
 
Impacts: 
Measure(s) 
PN-3a 
PN-3b 
Rationale:  The PN-3a and PN-3b measures are being removed at the direction of CMS and 
based on the IPPS Fiscal Year 2014 Final Rule. 
Description of Changes: 
Remove rows in Set Measure ID table: 
PN-3a 
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PN-3b 
Impacts: 
Measure(s) 
PN-3a 
PN-3b 
Rationale:  The PN-3a and PN-3b measures are being removed at the direction of CMS and 
based on the IPPS Fiscal Year 2014 Final Rule. 
Description of Changes: 
Remove measure information forms in their entirety. 
 
Impacts:   
Measure(s) 
PN-6 
PN-6a 
PN-6b 
Rationale:  The Pneumonia Antibiotic Consensus Recommendations tables have been 
revised to make them more organized and easier to follow. 
Description of Changes: 
Change Pneumonia Antibiotic Consensus Recommendations Table 
Review table in the manual document as it has significantly changed. 
 
Subsection 2.4 – Surgical Care Improvement Project (SCIP) 
Impacts:   
Set Measure ID# 
Rationale:  The Hospital IQR Program Measure, Surgery Patients with Perioperative 
Temperature Management, was removed in the IPPS Fiscal Year 2014 Final Rule. 
Description of Changes: 
Remove SCIP-Inf-10 row 
 
Impacts:   
SCIP Data Element List 
Anesthesia End Date  
Anesthesia End Time 
Anesthesia Start Date 
Anesthesia Start Time 
Rationale:  The Hospital IQR Program Measure, Surgery Patients with Perioperative 
Temperature Management, was removed in the IPPS Fiscal Year 2014 Final Rule. 
Description of Changes: 
Remove under ‘Collected For’ column: 
SCIP-Inf-10 
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Impacts:   
SCIP Data Element List 
Rationale:  The Hospital IQR Program Measure, Surgery Patients with Perioperative 
Temperature Management, was removed in the IPPS Fiscal Year 2014 Final Rule. 
Description of Changes: 
Remove rows: 
Anesthesia Type 
Intentional Hypothermia 
Temperature 
 
 
Impacts:   
SCIP Data Element List 
Rationale:  This change is to remove the reference to algorithms in general data elements to 
correct inconsistencies in data elements collected for all records. Measure algorithm 
information is identified in the XML file layout document. 
Description of Changes: 
Discharge Date 
Remove under ‘Collected For’ column: 
(Used in Algorithm for SCIP-Inf-4) 
 
ICD-9-CM Principal Procedure Code 
Change to: 
All Records 
 
Impacts:   
SCIP Initial Patient Population – Stratum Table 
Rationale:  The Hospital IQR Program Measure, Surgery Patients with Perioperative 
Temperature Management, was removed in the IPPS Fiscal Year 2014 Final Rule. 
Description of Changes: 
Change under ‘Measures’ column from:  
SCIP-Inf-4, 6, 9, and 10 
To: 
SCIP-Inf-4, 6, and 9 
 
Impacts:   
SCIP Initial Patient Population Algorithm 
Rationale:  The algorithm is being updated due to the removal of SCIP-Inf-10 from the 
manual. 
Description of Changes: 
Add: 
Age calculation and all associated logic. 
 
Add a branch to the left of the condition box checking for Principal Procedure code on table 
5.08. The new branch would check for any code not on tables 5.01-5.08 and not on 5.25, and if 
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true for The Joint Commission only, exits from the Initial Patient Population flow without 
assigning the case to any stratum, and therefore taking it out of sampling. 
 
Impacts:   
Algorithms 
Measure(s) 
SCIP-Inf-1 
SCIP-Inf-2 
SCIP-Inf-3 
Rationale:  This change will provide consistency in algorithm stratification across measure 
sets. 
Description of Changes: 
Change: 
Corresponding stratum to X when the overall measure category assignment is X.  
 
Impacts:   
Algorithms 
Measure(s) 
SCIP-Inf-1 
SCIP-Inf-2 
SCIP-Inf-3 
SCIP-Inf-4 
SCIP-Inf-6 
SCIP-Inf-9 
SCIP-CARD-2 
SCIP-VTE-2 
Rationale:  Update the measures due to the removal of SCIPinf-10 from the Manual. 
Description of Changes: 
Remove: 
Age calculation and all associated logic. 
 
Impacts:   
SCIP Sample Size Requirements 
Rationale:  Change made to reflect the appropriate measure name for SCIP-Inf-4. 
Description of Changes: 
Sample Size Examples 
Remove in first sentence: 
6 A.M. 
 
Impacts:   
Measure Information Form and Algorithm 
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Rationale:  The Hospital IQR Program Measure, Surgery Patients with Perioperative 
Temperature Management, was removed in the IPPS Fiscal Year 2014 Final Rule. 
Description of Changes: 
Remove:  
SCIP-Inf-10 measure information form in its entirety 
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Subsection 2.6 – Children’s Asthma Care (CAC) 
Impacts:   
CAC Data Element List 
Rationale:  This change is to remove the reference to algorithms in general data elements to 
correct inconsistencies in data elements collected for all records. Measure algorithm 
information is identified in the XML file layout document. 
Description of Changes: 
Admission Date 
Birthdate 
ICD-9-CM Principal Diagnosis Code 
Remove under ‘Collected For’ column: 
(Used in Algorithm for All CAC Measures) 
 
Impacts:   
Measure(s) 
CAC-1 
CAC-2 
CAC-3 
Rationale:  Updating CAC reference to provide current link to source. 
Description of Changes: 
Selected References 
Remove: 
National Center for Health Statistics, Center for Disease Control and Prevention, Asthma 
Prevalence, Health Care Use and Mortality, 2006-2008. Available from 
http://www.cdc.gov/nchs/products/pub/pubd, Accessed October 27, 2011. 
 
Add: 
Centers for Disease Control and Prevention. CDC Health Disparities and Inequalities Report 
— United States, 2011. MMWR 2011;60(Suppl):p 84-86. Available from 
http://www.cdc.gov/mmwr/pdf/other/su6001.pdf  Accessed February 7, 2014. 
 
Impacts:   
Algorithms 
Measure(s) 
CAC-1 
CAC-2 
Rationale:  This change will provide consistency in algorithm stratification across measure 
sets. 
Description of Changes: 
Change: 
Corresponding stratum to X when the overall measure category assignment is X.  
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Subsection 2.7 – Venous Thromboembolism (VTE) 
Impacts:   
VTE Data Element List 
Rationale:  This change is to remove the reference to algorithms in general data elements to 
correct inconsistencies in data elements collected for all records. Measure algorithm 
information is identified in the XML file layout document. 
Description of Changes: 
ICD-9-CM Other Diagnosis Codes 
ICD-9-CM Principal Diagnosis Code 
Remove under ‘Collected For’ column: 
(Used in Algorithm for All VTE Measures) 
ICD-9-CM Principal Procedure Code 
Remove under ‘Collected For’ column: 
(Used in Algorithm for VTE-1, VTE-2) 
 
Impacts:   
N/A 
Rationale:  This change is to provide information on the specified measures that are eligible 
for voluntary electronic submission for the Hospital IQR Program. 
Description of Changes: 
Add after Set Measure ID # table: 
For voluntary electronic submission of the Hospital Inpatient Quality (IQR) Reporting 
Program specified measures for the Medicare EHR Incentive Program Stage 2, this 
measure may be electronically submitted using a Quality Reporting Document 
Architecture (QRDA) Category-I Release 2 formatted file. 
   
For information about the requirements and technical specifications of the QRDA specifications 
and data submission, see the resources located on QualityNet, [Hospitals-Inpatient], 
Electronically Specified Clinical Quality Measures (eCQM) Reporting. If you have questions 
regarding the EHR Incentive Program measures collected for the Hospital IQR Program, 
please refer to the CMS website. For resource links see Appendix G. 
 
Impacts:   
VTE Data Element List 
Rationale:  The Technical Advisory Panel reviewed clinical scenarios presented and 
determined that an acceptable documentation needed to be defined for this new data element. 
Description of Changes: 
Change under “VTE Data Element Name” column: 
Reason for Discontinuation of Parenteral Therapy  
To 
Reason for Discontinuation of Parenteral Anticoagulation Therapy 
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Add under “VTE Data Element Name” column and “Collected For” column respectively: 
Reason for No Administration of VTE Prophylaxis  
VTE-6 
 
Impacts:   
Measure(s) 
VTE-3 
Rationale:  Clinical scenarios presented to the Technical Advisory Panel (TAP) justified the 
need for defined time frames, and the need for examples and clarifications to capture 
acceptable documentation for these data elements. 
Description of Changes: 
Description 
Change Reason for Discontinuation of Parenteral Therapy to: 
Reason for Discontinuation of Parenteral Anticoagulation Therapy 
 
Numerator Statement – Data Elements 
Change sixth bullet to: 
•  Reason for Discontinuation of Parenteral Anticoagulation Therapy 
 
Impacts:   
Algorithm 
Measure(s) 
VTE-3 
Rationale:  A data element name is being changed based on Technical Advisory Panel (TAP) 
feedback. 
Description of Changes: 
Change data element name of Reason for Discontinuation of Parenteral Therapy to:  
Reason for Discontinuation of Parenteral Anticoagulation Therapy. 
 
Impacts:   
Measure(s) 
VTE-6 
Rationale:  The Technical Advisory Panel reviewed clinical scenarios presented and 
determined that an acceptable documentation needed to be defined for this new data element. 
Description of Changes: 
Denominator Statement - Data Element 
Add bullet: 
Reason for No Administration of VTE Prophylaxis 
 
Impacts:   
Algorithm 
Measure(s) 
VTE-6 
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Rationale:  The Technical Advisory Panel reviewed clinical scenarios presented and 
determined that an acceptable documentation needed to be defined for this new data element. 
Description of Changes: 
Change allowable values of VTE Prophylaxis Status to ‘Yes’ and ‘No’. 
•  If VTE Prophylaxis Status is missing, the case will proceed to a Measure Category 
Assignment of X. 
•  If VTE Prophylaxis Status equals Yes, the case will proceed to a Measure Category 
Assignment of D. 
•  If VTE Prophylaxis Status equals No, continue processing and proceed to Reason for No 
Administration of VTE Prophylaxis 
Add a new branch of Reason for No Administration of VTE Prophylaxis when VTE Prophylaxis 
Status equals ‘No.' 
•  If Reason for No Administration of VTE Prophylaxis is missing, the case will proceed to 
a Measure Category Assignment of X. 
•  If Reason for No Administration of VTE Prophylaxis equals ‘Yes’, the case will proceed 
to a Measure Category Assignment of B. 
•  If Reason for No Administration of VTE Prophylaxis equals No, the case will proceed to 
a Measure Category Assignment of E. 
 
Subsection 2.8 – Stroke (STK) 
Impacts:   
STK Data Element List 
Rationale:  This change is to remove the reference to algorithms in general data elements to 
correct inconsistencies in data elements collected for all records. Measure algorithm 
information is identified in the XML file layout document. 
Description of Changes: 
ICD-9-CM Principal Diagnosis Code 
Remove under ‘Collected For’ column: 
(Used in Algorithm for STK-2, STK-3, STK-4, STK-5, STK-6) 
 
Impacts:   
N/A 
Rationale:  This change is to provide information on the specified measures that are eligible 
for voluntary electronic submission for the Hospital IQR Program. 
Description of Changes: 
Add after Set Measure ID # table: 
For voluntary electronic submission of the Hospital Inpatient Quality Reporting (IQR) 
Program specified measures for the Medicare EHR Incentive Program Stage 2, this 
measure may be electronically submitted using a Quality Reporting Document 
Architecture (QRDA) Category-I Release 2 formatted file. 
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For information about the requirements and technical specifications of the QRDA specifications 
and data submission, see the resources located on QualityNet, [Hospitals-Inpatient], 
Electronically Specified Clinical Quality Measures (eCQM) Reporting. If you have questions 
regarding the EHR Incentive Program measures collected for the Hospital IQR Program, 
please refer to the CMS website. For resource links see Appendix G. 
 
Impacts:   
Stroke Data Element List 
Rationale:  This change is to adjust the measure flow logic and add a new data element that 
will exclude cases who received IV thrombolytic therapy in 3 to 4.5 hours because a reason 
delayed initiation within 3 hours. 
Description of Changes: 
Add row under ‘Element Name’ and ‘Collected For’ column respectively: 
Reason for Extending the Initiation of IV Thrombolytic 
STK-4 
 
Impacts: 
Measure(s) 
STK-4 
Rationale:  This change is to remove the reference table of contraindications and warnings 
from the measure information to avoid confusion with the inclusion guidelines for abstraction 
for the data element Reason for Not Initiating IV Thrombolytic. 
Description of Changes: 
Rationale 
Add in third sentence after Food and Drug Administration: 
(FDA)  
 
Add second paragraph: 
The European Cooperative Acute Stroke Study (ECASS) III trial indicated that intravenous 
rtPA can be given safely to, and can improve outcomes for, carefully selected patients treated 
3 to 4.5 hours after stroke; however, as the NINDS investigators concluded, the earlier that IV 
thrombolytic therapy is initiated, the better the patient outcome.  Therefore, the target for IV t-
PA initiation remains within 3 hours of time last known well.  The administration of IV 
thrombolytic therapy beyond 3 hours of stroke symptom onset has not been FDA approved. 
   
Denominator Statement 
Excluded Populations 
Add new bullet: 
•  Patients with a documented Reason for Extending the Initiation of  IV Thrombolytic  
 
Data Elements 
Add new bullet: 
•  Reason for Extending the Initiation of IV Thrombolytic 
 
Selected References 
Add new reference: 
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•  U.S. Drug and Food Administration. (2002). “Label-Alteplase-Food and Drug.” 
 
Remove: 
Conditions Making the Administration of IV Thrombolytic Therapy Inadvisable 
Contraindications: 
•  CT findings of intracranial hemorrhage, subarachnoid hemorrhage, or major infarct 
signs 
•  History of intracranial hemorrhage, brain aneurysm, vascular malformation, or brain 
tumor 
•  Internal bleeding (less than 22 days) 
•  IV or IA t-PA given at a transferring hospital  
•  No IV access 
•  Patient/family refusal 
•  Platelets less than 100,000, PTT greater than 40 sec after heparin use  
•  PT greater than 15 or INR greater than 1.7, or unknown bleeding diathesis 
•  Recent intracranial or spinal surgery, head trauma, or stroke (less than 3 months) 
•  Recent surgery/trauma (less than15 days) 
•  Seizure at onset 
•  Suspicion of subarachnoid hemorrhage 
•  Systolic blood pressure greater than 185 or diastolic blood pressure greater than 110 
mm hg 
•  Unable to determine eligibility 
 
Remove: 
Warnings/Conditions that might lead to increased risk of bleeding or unfavorable outcomes: 
•  Acute pericarditis 
•  Advanced age 
•  Diabetic hemorrhagic retinopathy or other ophthalmic bleeding 
•  Glucose less than 50 or greater than 400 mg/dl 
•  Hemostatic defects including those secondary to severe renal or hepatic disease 
•  Left heart thrombus 
•  Life expectancy less than 1 year or severe co-morbid illness 
•  Myocardial infarction (MI) within the past 3 months 
•  Patient currently receiving oral anticoagulants (e.g. Warfarin sodium, Coumadin)  
•  Pregnancy 
•  Rapid improvement 
•  Septic thrombophlebitis or occluded AV cannula at seriously infected site 
•  Stroke severity – Too mild 
•  Stroke severity – Too severe (e.g., NIHSS greater than 22)  
•  Subacute bacterial endocarditis 
 
Impacts:   
Algorithm 
Measure(s) 
STK-4 
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Rationale:  This change is to adjust the measure flow logic and add a new data element that 
will exclude cases who received IV thrombolytic therapy in 3 to 4.5 hours because a reason 
delayed initiation within 3 hours. 
Description of Changes: 
Add one decision branch of “Timing I”  
•  When allowable value is "< 0 minute(s)", case proceeds to a Category Assignment ‘X’. 
 
Add another "Timing II" decision box           
•  When allowable value is "< 0 minute(s)", case proceeds to a Category Assignment ‘X’. 
•  When allowable value is "≥ 0 and ≤ 270 minute(s)", case will flow down to another 
"Timing II" 
•  When allowable value is ">270 minute(s)", case proceeds to a Category Assignment ‘D’. 
 
Change 
•  2nd Timing II allowable value from: 
             ≥ 0 and ≤ 180 
To:  ≥ 0 and ≤ 180 minute(s) 
 
•  2nd Timing II allowable value from: 
               > 180 
To:  > 180 and ≤ 270 minute(s) 
 
Add "Reason for Extending the Initiation of IV Thrombolytic" decision box 
•  When allowable value is “=N”, case proceed to a Category Assignment "D" 
•  When allowable value is “=Y”, case proceed to a Category Assignment "B" 
•  When allowable value is missing, case proceed to a Category Assignment "X" 
 
Impacts: 
Measure(s) 
STK-6 
Rationale:  The wording of “Included Populations” needed to be revised to clearly state which 
patients are included in the measure population. 
Description of Changes: 
Included Populations 
Add the word “AND” between the first and second bullet 
 
Change second bullet to: 
•  Patients who were on a lipid-lowering medication prior to hospital arrival as defined in 
Appendix C, Table 1.6, OR 
 
Change third bullet to: 
Patients with LDL-c not measured, OR 
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Impacts: 
Measure(s) 
STK-8 
Rationale:  The change is to revise wording of “Included Populations” to clearly state which 
patients are included in the measure population. 
Description of Changes: 
Included Populations 
Add the word “AND” between the first and second bullet 
 
Subsection 2.9 – Global Initial Patient Population (ED, IMM, TOB, SUB) 
Impacts:  
Global – Inpatient Population 
Initial Patient Population Algorithm 
Rationale:  Changes are being made to remove redundant verbiage and to provide 
clarification regarding the Global Initial Patient Population flow. 
Description of Changes: 
Global – Inpatient Population 
Change first sentence in fifth paragraph to: 
For The Joint Commission, hospitals must submit the same case for all applicable measure 
sets elected by the hospital (i.e., ED, IMM, SUB and TOB) under the Global Initial Patient 
Population. 
Change seventh paragraph to: 
For Emergency Department (ED), Immunization (IMM), Substance Use (SUB) and Tobacco 
Treatment (TOB) Initial Patient Population definitions and algorithms, please refer to the Global 
Initial Patient Population. 
Remove eighth paragraph: 
For Emergency Department, Immunization, Substance Use and Tobacco Treatment Initial 
Patient Population Algorithms please refer to the Global Initial Patient Population Algorithm. 
 
Initial Patient Population Algorithm 
Add returning arrows after each measure set's 'Reject Case Flag=No' to come back to the 
main flow and go to the next global measure set to ensure all the reject flags for applicable 
measure sets are set to No for any case that satisfies the  global IPP condition. 
 
 Subsection 2.10 - Emergency Department (ED) 
Impacts:   
ED Data Element List 
Rationale:  This change is to remove the reference to algorithms in general data elements to 
correct inconsistencies in data elements collected for all records. Measure algorithm 
information is identified in the XML file layout document. 
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Description of Changes: 
ICD-9-CM Principal Diagnosis Code 
Remove under ‘Collected For’ column: 
(Used in Algorithm for ED-1, ED-2) 
 
Impacts:   
N/A 
Rationale:  This change is to provide information on the specified measures that are eligible 
for voluntary electronic submission for the Hospital IQR Program. 
Description of Changes: 
Add after Set Measure ID # table: 
For voluntary electronic submission of the Hospital Inpatient Quality (IQR) Reporting 
Program specified measures for the Medicare EHR Incentive Program Stage 2, this 
measure may be electronically submitted using a Quality Reporting Document 
Architecture (QRDA) Category-I Release 2 formatted file. 
   
For information about the requirements and technical specifications of the QRDA specifications 
and data submission, see the resources located on QualityNet, [Hospitals-Inpatient],  
Electronically Specified Clinical Quality Meaures (eCQM) Reporting. If you have questions 
regarding the EHR Incentive Program measures collected for the Hospital IQR Program, 
please refer to the CMS website. For resource links see Appendix G. 
 
Impacts:   
Algorithms 
Measure(s) 
ED-1 
ED-2 
Rationale:  This change will provide consistency in algorithm stratification across measure 
sets. 
Description of Changes: 
Change: 
Corresponding stratum to X when the overall measure category assignment is X.  
Remove: UTD Counter and all associated logic. 
Remove: Variable Key box. 
Remove: Both Note Boxes near the “B” measure category assignment boxes. 
Remove: The “B” measure category assignment box after the “X” measure category 
assignment box. 
Add: Overall Rate Category Assignment decision box on Strata page before the ICD-9-CM 
Principal Diagnosis Code decision box. 
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Subsection 2.11.1 - Immunization (IMM) 
Impacts: 
IMM Data Element List 
Rationale:  This change is to remove the reference to algorithms in general data elements to 
correct inconsistencies in data elements collected for all records. Measure algorithm 
information is identified in the XML file layout document. 
Description of Changes: 
ICD-9-CM Other Diagnosis Codes 
ICD-9-CM Principal Diagnosis Code 
Remove under ‘Collected For’ column: 
 (Used in Algorithm for IMM-1) 
ICD-9-CM Other Procedure Codes 
ICD-9-CM Principal Procedure Code 
Remove under ‘Collected For’ column: 
(Used in Algorithm for All IMM Measures) 
 
Impacts:   
Algorithms 
Measure(s) 
IMM-1 
Rationale:  This change will provide consistency in algorithm stratification across measure 
sets. 
Description of Changes: 
Change: Overall measure category assignment X goes directly to Stop and does not go 
through stratification.   
 
Subsection 2.11.2 - Tobacco Treatment (TOB) 
Impacts:   
TOB Data Element Lists 
Rationale:  This change is to remove the reference to algorithms in general data elements to 
correct inconsistencies in data elements collected for all records. Measure algorithm 
information is identified in the XML file layout document. 
Description of Changes: 
ICD-9-CM Other Diagnosis Codes 
ICD-9-CM Principal Diagnosis Code 
Remove under ‘Collected For’ column: 
(Used in Algorithm for TOB-2, TOB-3) 
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Impacts:   
Tobacco Use Data Element List 
Rationale:  The current measure specifications exclude patients with cognitive impairment 
from all of the TOB and SUB measures, if there is documentation of cognitive impairment for 
the entire hospitalization. Since the alcohol use screen and/or tobacco use screen must be 
completed within 3 days after admission, cognitive impairment will now be evaluated in the 
Alcohol Use Status and Tobacco Use Status data elements, and the data element Cognitive 
Impairment will be removed from all of the TOB and SUB measures. 
Description of Changes: 
Remove Cognitive Impairment row 
 
Impacts:   
Measure(s) 
TOB-1 
Rationale:  The current measure specifications exclude patients with cognitive impairment 
from all of the TOB and SUB measures, if there is documentation of cognitive impairment for 
the entire hospitalization. Since the alcohol use screen and/or tobacco use screen must be 
completed within 3 days after admission, cognitive impairment will now be evaluated in the 
Alcohol Use Status and Tobacco Use Status data elements, and the data element Cognitive 
Impairment will be removed from all of the TOB and SUB measures. 
Description of Changes: 
Denominator Statement 
Data Elements 
Remove Cognitive Impairment 
Add Tobacco Use Status 
 
Impacts:   
Measure(s) 
TOB-1 
TOB-2 
TOB-2a 
TOB-3 
TOB-3a 
Rationale:  National Quality Forum (NQF) endorsement was obtained for SUB-1, SUB-2, 
SUB-2a, SUB-3, SUB-3a, TOB-1, TOB-2, TOB-2a, TOB-3 and TOB-3a. 
Description of Changes: 
Add at the top of page header: 
NQF ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE 
 
Impacts:   
Algorithms 
Measure(s) 
TOB-1 
TOB-2 
TOB-3 
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TOB-4 
Rationale:  This change is to provide clarification for programmers and abstractors. 
Description of Changes: 
Remove Cognitive Impairment decision point and logic branches below Comfort Measures 
Only decision point 
Add Tobacco Use Status Allowable Value (AV) 6  
•  Flow to category ‘B’ when AV equals to 6  
•  Remain unchanged when AV equals to 1,2,3,4,5 
 
Impacts:   
Algorithms 
Measure(s) 
TOB-2 
TOB-3 
Rationale:  This change will provide consistency in algorithm stratification across measure 
sets. 
Description of Changes: 
Change: 
Corresponding stratum to X when the overall measure category assignment is X.  
 
Impacts:  
Measure(s) 
TOB-2 
TOB-3 
TOB-4 
Rationale: The current measure specifications exclude patients with cognitive impairment from 
all of the TOB and SUB measures, if there is documentation of cognitive impairment for the 
entire hospitalization. Since the alcohol use screen and/or tobacco use screen must be 
completed within 3 days after admission, cognitive impairment will now be evaluated in the 
Alcohol Use Status and Tobacco Use Status data elements, and the data element Cognitive 
Impairment will be removed from all of the TOB and SUB measures.  
Description of Changes: 
Denominator Statement - Data Elements 
Remove Cognitive Impairment 
 
Impacts:   
Algorithm 
Measure(s) 
TOB-3 
Rationale:  This change is to move the first Prescription for Tobacco Cessation Medication 
decision point before category assigned to ‘E’ in the TOB-3 to avoid program dead end in 
TOB-3a.  
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Description of Changes: 
Add Prescription for Tobacco Cessation Medication point and logic branches below Referral 
for Outpatient Tobacco Cessation Counseling decision point 
•  If Prescription for Tobacco Cessation Medication value is missing, the case flows to 
category ‘X’ for Overall Rate Category Assignment   
•  If Prescription for Tobacco Cessation Medication equals to 3,  the case flows to 
category ‘B’ for Overall Rate Category Assignment 
•  If Prescription for Tobacco Cessation Medication equals to 1, 2, or 4, the case flows to 
connector ‘K’ 
 
Remove  Prescription for Tobacco Cessation Medication decision point and logic branches 
below recheck Tobacco Use Status decision point 
 
Impacts:   
Algorithms 
Measure(s) 
TOB-3 
TOB-4 
Rationale:  Change the order of Tobacco Use Status decision point and Discharge Disposition 
decision point in TOB-3 and TOB-4 to be consistent in the measure set. 
Description of Changes: 
Change Tobacco Use Status decision point and logic branches below Comfort Measures Only 
decision point. 
Change Discharge Disposition decision point and logic branches below Tobacco Use Status 
decision point. 
 
Subsection 2.11.3 - Substance Use (SUB) 
 
Impacts:   
Substance Use Data Element List 
Rationale:  The current measure specifications exclude patients with cognitive impairment 
from all of the TOB and SUB measures, if there is documentation of cognitive impairment for 
the entire hospitalization. Since the alcohol use screen and/or tobacco use screen must be 
completed within 3 days after admission, cognitive impairment will now be evaluated in the 
Alcohol Use Status and Tobacco Use Status data elements, and the data element Cognitive 
Impairment will be removed from all of the TOB and SUB measures. 
Description of Changes: 
Alcohol Use Status 
Add in ‘Collected For’ column: 
SUB-3, SUB-4 
 
Remove:  
Cognitive Impairment row 
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Impacts:   
SUB Data Element List 
Rationale:  This change is to remove the reference to algorithms in general data elements to 
correct inconsistencies in data elements collected for all records. Measure algorithm 
information is identified in the XML file layout document. 
Description of Changes: 
ICD-9-CM Other Diagnosis Codes 
ICD-9-CM Other Procedure Codes 
ICD-9-CM Principal Diagnosis Code 
ICD-9-CM Principal Procedure Code 
Remove under ‘Collected For’ column: 
(Used in Algorithm for SUB-3, SUB4) 
 
Impacts:   
Denominator Statement 
Measure(s) 
SUB-1 
SUB-2 
Rationale:  The current measure specifications exclude patients with cognitive impairment 
from all of the TOB and SUB measures, if there is documentation of cognitive impairment for 
the entire hospitalization. Since the alcohol use screen and/or tobacco use screen must be 
completed within 3 days after admission, cognitive impairment will now be evaluated in the 
Alcohol Use Status and Tobacco Use Status data elements, and the data element Cognitive 
Impairment will be removed from all of the TOB and SUB measures.   
Description of Changes: 
Data Elements 
Remove:  
Cognitive Impairment 
 
Impacts:   
Algorithm 
Measure(s) 
SUB-1 
SUB-2 
Rationale:  This change is to provide clarification for programmers and abstractors.   
Description of Changes: 
Remove Cognitive Impairment decision point and logic branches below Comfort Measures 
Only decision point 
Add Alcohol Use Status Allowable Value (AV) 7  
•  Flow to category ‘B’ when AV equals to 7  
•  Remain unchanged  when AV equals to 1,2,3,4,5,6 
 
Specifications Manual for Hospital Inpatient Quality Measures  Page 91 
Discharges 01-1-15 (1Q15) through 09-30-15 (3Q15) Release Notes Version 4.4 
Impacts:   
Measure(s) 
SUB-1 
SUB-2 
SUB-2a 
SUB-3 
SUB-3a 
Rationale:  National Quality Forum (NQF) endorsement was obtained for SUB-1, SUB-2, 
SUB-2a, SUB-3, SUB-3a, TOB-1, TOB-2, TOB-2a, TOB-3 and TOB-3a. 
Description of Changes: 
Add at the top of page header: 
NQF ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE 
 
Impacts:   
Measure(s) 
SUB-1 
SUB-3 
SUB-4 
Rationale:  The current measure specifications exclude patients with cognitive impairment 
from all of the TOB and SUB measures, if there is documentation of cognitive impairment for 
the entire hospitalization. Since the alcohol use screen and/or tobacco use screen must be 
completed within 3 days after admission, cognitive impairment will now be evaluated in the 
Alcohol Use Status and Tobacco Use Status data elements, and the data element Cognitive 
Impairment will be removed from all of the TOB and SUB measures.   
Description of Changes: 
Denominator Statement - Data Elements 
Add: 
Alcohol Use Status 
 
Remove:  
Cognitive Impairment 
 
Impacts:  Algorithms 
Measure(s) 
SUB-2 
SUB-3 
Rationale:  This change will provide consistency in algorithm stratification across measure 
sets. 
Description of Changes: 
Change: 
Corresponding stratum to X when the overall measure category assignment is X.  
 
Impacts:   
Algorithm 
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Measure(s) 
SUB-3 
Rationale:  This change is to move the first Prescription for Alcohol or Drug Disorder 
Medication decision point before category assigned to ‘E’ in SUB-3 to avoid program dead end 
in SUB-3a.  
Description of Changes: 
Add Prescription for Alcohol or Drug Disorder Medication decision point and logic branches 
below Referral for Addictions Treatment decision point 
•  If Prescription for Alcohol or Drug Disorder Medication value is missing, the case flows 
to category ‘X’ for Overall Rate Category Assignment 
•  If Prescription for Alcohol or Drug Disorder Medication equals to 3, the case flows to 
category ‘B’ for Overall Rate Category Assignment 
•  If Prescription for Alcohol or Drug Disorder Medication equals to 1, 2, or 4, the case 
flows to connector ‘K’ 
 
Remove  Prescription for Alcohol or Drug Disorder Medication decision point and logic 
branches below recheck Referral for Addictions Treatment decision point 
 
Impacts:   
Algorithm 
Measure(s) 
SUB-3 
SUB-4 
Rationale:  This change is to provide clarification for programmers and abstractors.   
Description of Changes: 
Remove Cognitive Impairment decision point and logic braches below Comfort Measures Only 
decision point 
 
Add Alcohol Use Status decision point and logic braches below Comfort Measures Only 
decision point 
•  Flow to category ‘B’ when AV equals to 7  
•  Flow down  when AV equals to 1,2,3,4,5,6 
 
SECTION 3 – Missing and Invalid Data 
No updates in this section. 
 
SECTION 4 – Population and Sampling Specifications 
No updates in this section. 
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SECTION 9 – Data Transmission 
Impacts:   
N/A 
Rationale:  Guidance added related to the transmission and processing of ICD codes for both 
the QIO Clinical and the Joint Commission’s Data Warehouses. 
Description of Changes: 
CMS and Joint Commission Guidelines for Submission of Hospital Clinical Data 
Change sub-header from: 
Principal and Other Diagnosis Codes 
To 
Principal and Other Diagnosis and Procedure Codes 
 
Add: 
•  Only valid ICD diagnosis and ICD procedure codes, as per the CMS master code tables, 
will be accepted into the QIO Clinical Warehouse and Joint Commission’s Data 
Warehouse. Submission of other codes not included on the CMS master code tables will 
result in cases being rejected from both warehouses. 
 
Impacts:   
N/A 
Rationale:  Changes made to the allowable measure set combinations related to the change 
in the SCIP Initial Patient Population. 
Description of Changes: 
CMS and Joint Commission Guidelines for Submission of Hospital Clinical Data 
Allowable Measure Set Combination per Episode of Care 
Change 1e to: 
e.  ED, IMM and SCIP for patients age 18 and older 
 
Change 2 to: 
2.  Joint Commission’s Data Warehouse only 
a.  ED, IMM, TOB, SUB and SCIP for patients age 18 and older 
b.  HF, ED, IMM, TOB, SUB and SCIP for patients age 18 and older 
c.  AMI, ED, IMM, TOB, SUB and SCIP for patients age 18 and older 
d.  PN, ED, IMM, TOB, SUB and SCIP for patients age 18 and older 
e.  STK, IMM, TOB, SUB and SCIP for patients age 18 and older 
f.  ED, IMM, TOB, SUB and CAC for patients age 2 to under the age of 18 
g.  ED, IMM, TOB and SUB  
 
Add new bullet under 4: 
f.  CAC and SCIP 
 
Impacts:   
N/A 
Rationale:  To provide clarification and consistency on how the patient age is calculated. 
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Description of Changes: 
Patient-Level Clinical Data XML File Layout   
Patient 
Add new paragraph: 
For algorithms that calculate the patient age, Admission Date minus the Birthdate, use the 
month and day portion of admission date and birthdate to yield the most accurate age. The 
traditional approach of counting months or years by the birthday date or the first day of the 
next month, when the exact date does not exist in the calendar for the end point, must be used 
when calculating the patient age. For example, if calculating the age by year, a patient born on 
March 31st turns one year older on March 31st. A patient born on February 29th, in a leap year, 
has a birthday on February 29th on all leap years, and March 1st in all non-leap years. Or if 
calculating age by month, if a patient is born on March 31st the patient turns 6 months on 
October 1st and not on September 30th. Since the 31 date does not exist in September, you 
would move to the first day of the next month, which would be October 1st, to add one month to 
the patient age. 
 
Transmission Alphabetical Data Dictionary 
Impacts:   
National Provider Identifier (NPI) 
Rationale:  The verbiage used in data elements collected for all records is being updated. 
Description of Changes: 
Suggested Data Sources 
Change to:  
UB-04 
 
Hospital Clinical Data XML File Layout 
Impacts:  Hospital Clinical Data – Detail Elements Information 
Rationale:  The changes are being made to align with the specifications manual alphabetical 
data dictionary. 
Description of Changes: 
Remove the following elements: 
Anesthesia Type 
Aspirin Prescribed at Discharge 
Blood Culture Collected 
Cognitive Impairment 
Discharge Instructions Address Activity 
Discharge Instructions Address Diet 
Discharge Instructions Address Follow-up 
Discharge Instructions Address Medications 
Discharge Instructions Address Symptoms Worsening 
Discharge Instructions Address Weight Monitoring 
Initial Blood Culture Collection Date 
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Initial Blood Culture Collection Time 
Intentional Hypothermia 
LDL-c Less Than 100 mg/dL 
Reason for No Aspirin at Discharge 
Temperature 
 
Impacts:   
Hospital Clinical Data – Detail Elements Information 
ACEI Prescribed at Discharge 
ARB Prescribed at Discharge  
Reason for No ACEI and No ARB at Discharge 
LSVD 
Rationale:  The changes are being made to align with the specifications manual alphabetical 
data dictionary. 
Description of Changes: 
Remove:  
HF-3 from Applicable Measure(s) and Programming Notes columns 
 
Impacts:   
Hospital Clinical Data – Detail Elements Information 
Alcohol Use Status 
Rationale:  The changes are being made to align with the specifications manual alphabetical 
data dictionary. 
Description of Changes: 
Add new Answer Code and Answer Value: 
7  The patient was not screened for alcohol use during the first three days of admission 
because of cognitive impairment. 
Change Applicable Measures(s)  
From 
SUB-1, SUB-2 
To 
All SUB Measures 
 
Impacts:   
Hospital Clinical Data – Detail Elements Information 
Anesthesia End Date 
Anesthesia End Time 
Anesthesia Start Time 
Rationale:  The changes are being made to align with the specifications manual alphabetical 
data dictionary. 
Description of Changes: 
Remove from the Applicable Measure(s) column: 
SCIP-Inf-10 
Remove from the Programming Notes: 
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Collected by CMS as Voluntary Only: SCIP-Inf-10 
Not Accepted by The Joint Commission: SCIP-Inf-10 
 
Impacts:  
Hospital Clinical Data – Detail Elements Information 
Anesthesia Start Date 
Rationale:  The changes are being made to align with the specifications manual alphabetical 
data dictionary. 
Description of Changes: 
Remove from the Programming Notes: 
Collected by CMS as Voluntary Only: SCIP-Inf-10 
Not Accepted by The Joint Commission: SCIP-Inf-10 
Impacts:   
Hospital Clinical Data – Detail Elements Information 
Antibiotic Administration Date 
Rationale:  The changes are being made to align with the specifications manual alphabetical 
data dictionary. 
Description of Changes: 
Remove from the Applicable Measure(s) column 
PN-3b 
Remove from the Programming Notes 
Collected by CMS as Voluntary Only: PN-3b 
Not Accepted by The Joint Commission: PN-3b 
CMS Only: Required for transmission of PN-3b 
 
Impacts:   
Hospital Clinical Data – Detail Elements Information 
Antibiotic Administration Route 
Rationale:  The changes are being made to align with the specifications manual alphabetical 
data dictionary. 
Description of Changes: 
Remove from Programming Notes: 
CMS Only: Required for transmission of PN-3b 
 
Impacts:   
Hospital Clinical Data – Detail Elements Information 
Antibiotic Name 
Rationale:  The changes are being made to align with the specifications manual alphabetical 
data dictionary. 
Description of Changes: 
Remove from the Applicable Measure(s) column 
PN-3b 
Remove from the Programming Notes 
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Collected by CMS as Voluntary Only: PN-3a, PN-3b 
PN-3a from the Collected by The Joint Commission Only 
Not Accepted by The Joint Commission: PN-3b 
 
Impacts:   
Hospital Clinical Data – Detail Elements Information 
Antibiotic Received 
Antibiotic Administration Time 
Rationale:  The changes are being made to align with the specifications manual alphabetical 
data dictionary. 
Description of Changes: 
Remove from the Applicable Measure(s) column: 
PN-3b 
Remove from the Programming Notes: 
Collected by CMS as Voluntary Only: PN-3b 
Not Accepted by The Joint Commission: PN-3b 
 
Impacts:   
Hospital Clinical Data – Detail Elements Information 
Arrival Date 
Arrival Time 
Pneumonia Diagnosis: ED/Direct Admit 
Rationale:  The changes are being made to align with the specifications manual alphabetical 
data dictionary.  
Description of Changes: 
Remove from the Applicable Measure(s) column: 
PN-3a and PN-3b 
Remove from the Programming Notes: 
PN-3a and PN-3b from the Collected by CMS as Voluntary Only 
PN-3a from the Collected by The Joint Commission Only 
Not Accepted by The Joint Commission: PN-3b 
 
Impacts:   
Hospital Clinical Data – Detail Elements Information 
Atrial Fibrillation/Flutter 
Rationale:  The changes are being made to align with the specifications manual alphabetical 
data dictionary. 
Description of Changes: 
Change Suggested Data Collection Question to: 
Was there physician/APN/PA documentation of a diagnosis, signed ECG tracing, or a history 
of ANY atrial fibrillation/flutter in the medical record? 
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Impacts: 
Hospital Clinical Data – Detail Elements Information 
Chest X-Ray 
Rationale:  The changes are being made to align with the specifications manual alphabetical 
data dictionary. 
Description of Changes: 
Change under the Applicable Measure(s) column: 
All PN Measures to PN-6, PN-6a, PN-6b 
Remove from the Programming Notes: 
Collected by CMS as Voluntary Only: PN-3a, PN-3b 
Not Accepted by The Joint Commission: PN-3b 
 
Impacts:   
Hospital Clinical Data – Detail Elements Information 
Clinical Trial 
Rationale:  The changes are being made to align with the specifications manual alphabetical 
data dictionary. 
Description of Changes: 
Remove from the Programming Notes: 
AMI-2, AMI-10, HF-3, and PN-3a from the Collected by The Joint Commission Only 
Not Accepted by The Joint Commission: HF-1, PN-3b 
AMI-2, AMI-10, HF-1, HF-3, PN-3a and PN-3b from the Collected by CMS as Voluntary Only 
 
Impacts:   
Hospital Clinical Data – Detail Elements Information 
Comfort Measures Only 
Rationale:  The changes are being made to align with the specifications manual alphabetical 
data dictionary. 
Description of Changes: 
Remove from the Applicable Measure(s) column: 
AMI-2 and AMI-10 
Change under the Applicable Measures(s) column: 
All HF Measures to HF-2 
Remove from the Programming Notes: 
AMI-2, AMI-10, HF-3, PN-3a from the Collected by The Joint Commission Only 
Not Accepted by The Joint Commission: HF-1, PN-3b 
AMI-2, AMI-10, HF-1, HF-3, PN-3a and PN-3b from the Collected by CMS as Voluntary Only 
 
Impacts: 
Hospital Clinical Data – Detail Elements Information 
Date Last Known Well 
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Rationale:  The changes are being made to align with the specifications manual alphabetical 
data dictionary. 
Description of Changes: 
Change Suggested Data Collection Question to: 
What was the date associated with the time at which the patient was last known to be well or at 
his or her baseline state of health? 
 
Impacts:   
Hospital Clinical Data – Detail Elements Information 
Discharge Disposition 
Rationale:  The changes are being made to align with the specifications manual alphabetical 
data dictionary. 
Description of Changes: 
Change under the Applicable Measure(s) column: 
All HF Measures to HF-2 
Remove from the Programming Notes: 
AMI-2, AMI-10 and HF-3 from the Collected by The Joint Commission Only 
HF-1 and PN-3b from the Not Accepted by The Joint Commission 
AMI-2, AMI-10, HF-1, HF-3, and PN-3b from the Collected by CMS as Voluntary Only 
 
Impacts:   
Hospital Clinical Data – Detail Elements Information 
ICD-9-CM Other Diagnosis Codes 
Rationale:  The changes are being made to align with the specifications manual alphabetical 
data dictionary. 
Description of Changes: 
Change Answer Value from ICD-9-CM Diagnosis Code, with or without decimal 
To: 
Any valid diagnosis code as per the CMS ICD-9-CM master code table ICD-9-CM Full and 
Abbreviated Code Titles): 
http://www.cms.gov/Medicare/Coding/ICD9ProviderDiagnosticCodes/codes.html. 
Change under Applicable Measure(s) Used for IMM-1, All PN Measures, All VTE Measures, 
Sub-3, SUB-4, TOB-2, TOB-3, TOB-4 
To:  
Used in the algorithm for IMM-1, All VTE Measures, SUB-2, SUB-3, SUB-4, TOB-2, TOB-3, 
TOB-4 
Remove under Programming Notes: 
PN-3a from Collected by CMS as Voluntary Only 
PN-3a, PN-6a, PN-6b from Collected by The Joint Commission Only 
PN-3b from the Not Accepted by the Joint Commission Only 
Add under Programming Notes: 
SUB-2 to the Collected by The Joint Commission Only 
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Impacts:   
Hospital Clinical Data – Detail Elements Information 
ICD-9-CM Other Procedure Codes 
Rationale:  The changes are being made to align with the specifications manual alphabetical 
data dictionary. 
Description of Changes: 
Change Answer Value from ICD-9-CM Procedure Code, with or without decimal 
To:  
Any valid procedure code as per the CMS ICD-9-CM master code table ICD-9-CM Full and 
Abbreviated Code Titles):  
http://www.cms.gov/Medicare/Coding/ICD9ProviderDiagnosticCodes/codes.html. 
Change under Applicable Measure(s) Used for AMI-8, AMI-8a, All HF Measures, All IMM 
Measures, SUB-3, SUB-4  
To:  
Used in the algorithm for AMI-8, AMI-8a, All IMM Measures, SCIP-Inf-1, SCIP-Inf-2, SCIP-Inf-
9, SUB-3, SUB-4 
Remove under Programming Notes: 
HF-3 from Collected by The Joint Commission Only 
HF-1 from Not Accepted by The Joint Commission 
HF-1 and HF-3 from Collected by CMS as Voluntary Only 
 
Impacts:   
Hospital Clinical Data – Detail Elements Information 
ICD-9-CM Principal Diagnosis Code 
Rationale:  The changes are being made to align with the specifications manual alphabetical 
data dictionary. 
Description of Changes: 
Change Answer Value from ICD-9-CM Diagnosis Code, with or without decimal  
To:  
Any valid diagnosis code as per the CMS ICD-9-CM master code table ICD-9-CM Full and 
Abbreviated Code Titles): 
http://www.cms.gov/Medicare/Coding/ICD9ProviderDiagnosticCodes/codes.html. 
Change under Applicable Measure(s) Used for IMM-1, STK-2, STK-3, STK-4, STK-5, STK-6, 
SUB-3, SUB-4, TOB-2, TOB-3, TOB-4, All VTE Measures, ED-1, ED-2  
To:  
Used in the algorithm for IMM-1 STK-2, STK-3, STK-4, STK-5, STK-6, SUB-2, SUB-3, SUB-4, 
TOB-2, TOB-3, TOB-4, All VTE Measures, ED-1, ED-2, SCIP-Inf-1, SCIP-Inf-2, SCIP-Inf-3, 
SCIP-Inf-4, SCIP-VTE-2 
Remove under Programming Notes: 
PN-3a from Collected by CMS as Voluntary Only 
PN-3a, PN-6a, PN-6b from Collected by The Joint Commission Only 
PN-3b from the Not Accepted by the Joint Commission Only 
Add under Programming Notes: 
SUB-2 to the Collected by The Joint Commission Only 
 
Specifications Manual for Hospital Inpatient Quality Measures  Page 101 
Discharges 01-1-15 (1Q15) through 09-30-15 (3Q15) Release Notes Version 4.4 
Impacts:   
Hospital Clinical Data – Detail Elements Information 
ICD-9-CM Principal Procedure Code 
Rationale:  The changes are being made to align with the specifications manual alphabetical 
data dictionary. 
Description of Changes: 
Change Answer Value from ICD-9-CM Procedure Code, with or without decimal  
To:  
Any valid procedure code as per the CMS ICD-9-CM master code table ICD-9-CM Full and 
Abbreviated Code Titles): 
http://www.cms.gov/Medicare/Coding/ICD9ProviderDiagnosticCodes/codes.html. 
Change under Applicable Measure(s) Used in AMI-8, AMI-8a, All HF Measures, All IMM 
Measures, All SCIP Measures, VTE-1, VTE-2, SUB-3, SUB-4  
To:  
Used in the algorithm for AMI-8, AMI-8a, All IMM Measures, SCIP-Inf-1, SCIP-Inf-2, SCIP-Inf-
3, SCIP-Inf-4, SCIP-Inf-9, SCIP-Card-2, SCIP-VTE-2, VTE-1, VTE-2, SUB-3, SUB-4 
Remove under Programming Notes: 
HF-3 and SCIP-Inf-6 from Collected by The Joint Commission Only 
HF-1 and SCIP-Inf-10 from Not Accepted by The Joint Commission 
HF-1, HF-3, SCIP-Inf-6 and SCIP-Inf-10 from Collected by CMS as Voluntary Only 
 
Impacts:  
Hospital Clinical Data – Detail Elements Information 
ICU Admission or Transfer 
Transfer from Another Hospital or ASC 
Rationale:  The changes are being made to align with the specifications manual alphabetical 
data dictionary. 
Description of Changes: 
Remove from the Applicable Measure(s) column 
PN-3a 
Remove from the Programming Notes 
Collected by CMS as Voluntary Only: PN-3a 
PN-3a from the Collected by The Joint Commission Only 
 
Impacts:   
Hospital Clinical Data – Detail Elements Information 
ICU VTE Prophylaxis 
Rationale:  The changes are being made to align with the specifications manual alphabetical 
data dictionary. 
Description of Changes: 
Change the Suggested Data Collection Question to 
What type of VTE prophylaxis was administered in the ICU? 
 
Impacts:   
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Hospital Clinical Data – Detail Elements Information 
ICU VTE Prophylaxis Date 
Rationale:  The changes are being made to align with the specifications manual alphabetical 
data dictionary. 
Description of Changes: 
Change Suggested Data Collection Question to:  
What date was the VTE prophylaxis administered in the ICU? 
 
Impacts:   
Hospital Clinical Data – Detail Elements Information 
Initial ECG Interpretation 
Rationale:  The changes are being made to align with the specifications manual alphabetical 
data dictionary. 
Description of Changes: 
Change Suggested Data Collection Question to: 
Is there documentation of ST-segment elevation on the electrocardiogram (ECG) performed 
closest to hospital arrival? 
 
Impacts:   
Hospital Clinical Data – Detail Elements Information 
INR Value 
Rationale:  The changes are being made to align with the specifications manual alphabetical 
data dictionary. 
Description of Changes: 
Change Suggested Data Collection Question to: 
Was there documentation of an INR value greater than or equal to 2.0 on the day of or the day 
after the last dose of the parenteral anticoagulation therapy? 
 
Impacts:   
Hospital Clinical Data – Detail Elements Information 
Prescription for Alcohol or Drug Disorder Medication 
Prescription for Tobacco Cessation Medication 
Rationale:  The changes are being made to align with the specifications manual alphabetical 
data dictionary. 
Description of Changes: 
Change the following Answer Value to: 
3          The patient’s residence is not in the USA. 
 
Impacts:   
Hospital Clinical Data – Detail Elements Information 
Reason for Discontinuation of Parenteral Therapy 
Rationale:  The changes are being made to align with the specifications manual alphabetical 
data dictionary. 
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Description of Changes: 
Change Question from:  
Reason for Discontinuation of Parenteral Therapy  
To  
Reason for Discontinuation of Parenteral Anticoagulation Therapy 
Change Suggested Data Collection Question to:  
Is there a reason for discontinuation of the parenteral anticoagulation therapy, documented by 
a physician/APN/PA or pharmacist on the same day or the day before the order for the 
discontinuation? 
 
Impacts:   
Hospital Clinical Data – Detail Elements Information 
Reason for Extending the Initiation of IV Thrombolytic 
Reason for No Administration of VTE Prophylaxis 
Rationale:  The changes are being made to align with the specifications manual alphabetical 
data dictionary. 
Description of Changes: 
Add the following new elements:  
Reason for Extending the Initiation of IV Thrombolytic 
Reason for No Administration of VTE Prophylaxis 
 
Impacts:   
Hospital Clinical Data – Detail Elements Information 
Reason for No Overlap Therapy 
Rationale:  The changes are being made to align with the specifications manual alphabetical 
data dictionary. 
Description of Changes: 
Change Suggested Data Collection Question to:  
Is there physician/APN/PA or pharmacist documentation on the day of or the day after the VTE 
Diagnostic Test, of a reason why parenteral anticoagulation therapy and warfarin were not 
administered on the same day? 
 
Impacts:   
Hospital Clinical Data – Detail Elements Information 
Reason for No VTE Prophylaxis – Hospital Admission 
Rationale:  The changes are being made to align with the specifications manual alphabetical 
data dictionary. 
Description of Changes: 
Change Suggested Data Collection Question to:  
Is there physician/APN/PA or pharmacist documentation why VTE prophylaxis was not 
administered at hospital admission? 
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Impacts:   
Hospital Clinical Data – Detail Elements Information 
Reason for No VTE Prophylaxis – ICU Admission 
Rationale:  The changes are being made to align with the specifications manual alphabetical 
data dictionary. 
Description of Changes: 
Change Suggested Data Collection Question to:  
Is there physician/APN/PA documentation why VTE prophylaxis was not administered at ICU 
admission or transfer? 
 
Impacts:   
Hospital Clinical Data – Detail Elements Information 
Reason for Not Initiating IV Thrombolytic 
Rationale:  The changes are being made to align with the specifications manual alphabetical 
data dictionary. 
Description of Changes: 
Change Suggested Data Collection Question to:  
Is there documentation on the day of or day after hospital arrival of a reason for not initiating IV 
thrombolytic? 
 
Impacts:   
Hospital Clinical Data – Detail Elements Information 
Reason for Not Prescribing Statin Medication at Discharge 
Statin Medication Prescribed at Discharge 
Rationale:  The changes are being made to align with the specifications manual alphabetical 
data dictionary. 
Description of Changes: 
Remove AMI-10 from the Applicable Measures(s) column 
Remove from Programming Notes: 
Collected by the Joint Commission Only: AMI-10 
Collected by CMS as Voluntary Only: AMI-10 
 
Impacts:   
Hospital Clinical Data – Detail Elements Information 
Referral for Addictions Treatment 
Rationale:  The changes are being made to align with the specifications manual alphabetical 
data dictionary. 
Description of Changes: 
Change the following Answer Values to: 
1  The referral to addictions treatment was made by the healthcare provider or health care 
organization at any time prior to discharge. 
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2  Referral information was given to the patient at discharge but the appointment was not 
made by the provider or health care organization prior to discharge. 
4         The patient’s residence is not in the USA. 
 
Impacts:   
Hospital Clinical Data – Detail Elements Information 
Referral for Outpatient Tobacco Cessation Counseling 
Rationale:  The changes are being made to align with the specifications manual alphabetical 
data dictionary. 
Description of Changes: 
Change the following Answer Values to: 
1  The referral to outpatient tobacco cessation counseling treatment was made by the 
healthcare provider or the health care organization at any time prior to discharge. 
2  Referral information was given to the patient at discharge but the appointment was not 
made by the provider or health care organization prior to discharge. 
4         The patient’s residence is not in the USA. 
 
Impacts:   
Hospital Clinical Data – Detail Elements Information 
Tobacco Use Status 
Rationale:  The changes are being made to align with the specifications manual alphabetical 
data dictionary. 
Description of Changes: 
Change Field Size from 2 to 1. 
 
Add new Answer Code and Answer Value: 
6  The patient was not screened for tobacco use during the first three days of admission 
  because of cognitive impairment. 
 
Impacts:   
Hospital Clinical Data – Detail Elements Information 
VTE Confirmed 
Rationale:  The changes are being made to align with the specifications manual alphabetical 
data dictionary. 
Description of Changes: 
Change Suggested Data Collection Question to:  
Is there physician/APN/PA documentation that the patient had a VTE Diagnostic Test and a 
VTE was confirmed in one of the defined locations within four days prior to arrival, or anytime 
during the hospitalization? 
 
Impacts:   
Hospital Clinical Data – Detail Elements Information 
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VTE Diagnostic Test 
Rationale:  The changes are being made to align with the specifications manual alphabetical 
data dictionary. 
Description of Changes: 
Change Suggested Data Collection Question to:  
Is there documentation that a diagnostic test was performed within four days prior to arrival or 
anytime during the hospitalization? 
 
Impacts:   
Hospital Clinical Data – Detail Elements Information 
VTE Present at Admission 
Rationale:  The changes are being made to align with the specifications manual alphabetical 
data dictionary. 
Description of Changes: 
Change Suggested Data Collection Question to:  
Was there any documentation by the physician/APN/PA that VTE was diagnosed or suspected 
on arrival to the day after admission? 
 
Impacts:   
Hospital Clinical Data – Detail Elements Information 
VTE Prophylaxis Date 
Rationale:  The changes are being made to align with the specifications manual alphabetical 
data dictionary. 
Description of Changes: 
Change Suggested Data Collection Question to: 
What date was the VTE prophylaxis administered after hospital admission? 
 
Impacts:   
Hospital Clinical Data – Detail Elements Information 
VTE Prophylaxis Status 
Rationale:  The changes are being made to align with the specifications manual alphabetical 
data dictionary. 
Description of Changes: 
Change Suggested Data Collection Question to:  
Was VTE prophylaxis administered between the admission date and the VTE Diagnostic Test 
order date? 
Change Answer Code and Answer Values to: 
N      No 
Y      Yes 
 
Impacts:   
Hospital Clinical Data – Detail Elements Information 
Warfarin Administration 
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Rationale:  The changes are being made to align with the specifications manual alphabetical 
data dictionary. 
Description of Changes: 
Change Suggested Data Collection Question to:  
Was warfarin administered any time after the VTE Diagnostic Test? 
 
Hospital Initial Patient Population Data XML File Layout 
No updates in this section. 
 
SECTION 10 – CMS Outcome Measures (Claims Based) 
Subsection 10.1 – Introduction Risk Standardized Mortality Measures 
Impacts:   
Introduction 
Rationale:  This change is to provide clarification to the abstractor. 
Description of Changes: 
Change third sentence in fourth paragraph to: 
Questions and comments about the mortality measures should be directed to 
cmsmortalitymeasures@yale.edu. 
Remove fourth sentence in fourth paragraph: 
Questions and comments about the COPD measure can be sent to copdmortality@yale.edu, 
and for the stroke measure, questions and comments can be directed to 
strokemortality@yale.edu. 
 
Subsection 10.2 – Introduction Risk Standardized Readmission and Complication 
Measures 
Impacts:   
Introduction 
Rationale:  This change is to provide clarification to the abstractor. 
Description of Changes: 
Change third sentence in fourth paragraph to: 
Questions and comments about the readmission measures should be directed to 
cmsreadmissionmeasures@yale.edu.  
Remove fifth sentence in fourth paragraph: 
For the COPD measure, questions and comments can be sent to copdreadmission@yale.edu, 
and for the stroke measure, questions and comments can be sent to 
strokereadmission@yale.edu. 
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Subsection 10.3 – Agency for Healthcare Research and Quality (AHRQ) Measures 
Impacts:   
Agency for Healthcare Research and Quality (AHRQ) Claims-Based Quality Measures (No 
Hospital Data Submission Required) 
Rationale:  This change is to correct the link for questions regarding the Agency for 
Healthcare Research and Quality’s (AHRQ) Patient Safety Indicators (PSIs) contact 
information. 
Description of Changes: 
Change third paragraph to: 
For questions regarding the technical specifications for the Agency for Healthcare Research 
and Quality’s (AHRQ) Patient Safety Indicators (PSIs) contact: 
support@qualityindicators.ahrq.gov or: (888) 512–6090. 
 
Subsection 10.4 – Healthcare Associated Infections (HAI) Measures 
No updates in this section. 
 
Subsection 10.5 – CMS Payment Measures  
Impacts:   
N/A 
Rationale:  This measure is being included to provide a comprehensive set of specifications 
for the claims-based measures in the aligned manual. 
Description of Changes: 
Add new measure: 
Medicare Spending Per Beneficiary (MSPB) 
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Subsection 10.6 – Structural Measures 
Impacts:  
Inpatient Web-Based Measure 
Rationale:  This change is to provide information on the specified measures that are eligible 
for voluntary electronic submission for the Hospital IQR Program. 
 
Description of Changes: 
Add after last paragraph: 
For voluntary electronic submission of the Hospital Inpatient Quality  Reporting 
(IQR) Program specified measures for the Medicare EHR Incentive Program Stage 
2, this measure may be electronically submitted using a Quality Reporting 
Document Architecture (QRDA) Category-I Release 2 formatted file. 
   
For information about the requirements and technical specifications of the QRDA specifications 
and data submission, see the resources located on QualityNet, [Hospitals-Inpatient], 
Electronically Specified Clinical Quality Measures (eCQM) Reporting . If you have questions 
regarding the EHR Incentive Program measures collected for the Hospital IQR Program, 
please refer to the CMS website. For resource links see Appendix G. 
 
APPENDICES 
Appendix A – ICD-9-CM Code Tables 
Impacts:   
Table 7.02 Obstetrics 
Rationale:  Obstetrical tables were reviewed by the Technical Advisory Panel and edits were 
suggested. 
Description of Changes: 
Add row: 
648.33   DRUG DEPENDENCE-ANTEPART 
648.34   DRUG DEPENDENCE-POSTPART 
 
Remove entire row for codes listed below: 
675.02 
675.12 
675.22 
675.80 
675.81 
675.82 
675.90 
675.91 
675.92 
676.02 
676.04 
676.12 
Specifications Manual for Hospital Inpatient Quality Measures  Page 110 
Discharges 01-1-15 (1Q15) through 09-30-15 (3Q15) Release Notes Version 4.4 
676.14 
676.40 
676.41 
676.42 
676.43 
676.44 
676.50 
676.51 
676.52 
676.53 
676.54 
676.60 
676.61 
676.62 
676.63 
676.64 
676.80 
676.81 
676.82 
676.83 
676.84 
676.90 
676.91 
676.92 
676.93 
676.94 
 
Impacts:   
Table 12.5 Chronic Obstructive Pulmonary Disease (COPD) 
Rationale:  The Advisory Committee on Immunization Practices does not specify that 
individuals diagnosed with emphysematous bleb need to receive the pneumococcal vaccine. 
Description of Changes: 
Remove row: 
492.0  EMPHYSEMATOUS BLEB 
 
Impacts:   
Table 13.1 Alcohol Dependence  
Rationale:  A code is being removed, since it does not identify patients with an alcohol 
dependence problem. In addition, codes are being added to identify patients with alcohol 
dependence. 
Description of Changes: 
Remove row: 
570  ACUTE NECROSIS OF LIVER 
Add: 
303.03  AC ALCOHOL INTOX-REMISS 
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303.93  ALCOH DEP NEC/NOS-REMISS 
305.00  ALCOHOL ABUSE-UNSPEC 
305.01  ALCOHOL ABUSE-CONTINUOUS 
305.02  ALCOHOL ABUSE-EPISODIC 
305.03  ALCOHOL ABUSE-IN REMISS 
571.0  ALCOHOLIC FATTY LIVER 
980.0  TOXIC EFF ETHYL ALCOHOL 
980.9  TOXIC EFFECT ALCOHOL NOS 
 
Impacts:   
Table 13.2 Drug Dependence 
Rationale:  A code is being removed, since it does not identify patients with an alcohol 
dependence problem. 
Description of Changes: 
Remove row: 
357.6  NEUROPATHY DUE TO DRUGS 
 
Appendix C – Medication Tables 
Impacts: 
Table 1.2 ACEIs 
Rationale:  This change is to add a new FDA-approved Angiotensin Converting Enzyme 
Inhibitor (ACEI) medication. 
Description of Changes: 
Add: 
Epaned 
 
Impacts:   
Table 1.6 Lipid-Lowering Medications 
Rationale:  This change is to add new FDA-approved lipid-lowering medications. 
Description of Changes: 
Add: 
Atorvastatin/ezetimibe 
Icosapent-Ethyl 
Juxtapid 
Kynamro 
Liptruzet 
Lomitapide 
Mipomersen Sodium 
Vascepa 
 
Impacts: 
Table 6.2 Reliever Medications – CAC 
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Rationale:  This change is to add new FDA-approved medications for consistency with 
guidelines. 
Description of Changes: 
Add row: 
Left column: Auvi-Q 
Right column: Epinephrine 
 
Add row: 
Left column: Combivent Respimat 
Right column: Albuterol/Ipratropium 
 
Impacts: 
Table 6.3 Systemic Corticosteroid Medications – CAC 
Rationale:  This change is to add new FDA-approved medications for consistency with 
guidelines. 
Description of Changes: 
Add row: 
Left column: AsmalPred 
Right column: Prednisolone 
 
Add row: 
Left column: Baycadron 
Right column: Dexamethasone 
 
Add row: 
Left column: Rayos 
Right column: Prednisone 
 
Impacts:   
Table 8.1 Statin Medications 
Rationale:  This change is to add a new FDA-approved statin combination medication. 
Description of Changes: 
Add: 
Atorvastatin/ezetimibe 
Liptruzet 
 
Impacts: 
Table 8.2 Antithrombotic Medications – Stroke 
Table 8.3 Anticoagulant Medications - Stroke 
Rationale:  This change is to align Stroke medications with the new Anticoagulation Therapy 
table in Appendix H. 
Description of Changes: 
Add: 
Acova 
Hirudin 
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Appendix D – Glossary of Terms 
 
 
Appendix E – Overview of Measure Information Form and Flowchart Formats 
Impacts:   
N/A 
Rationale:  Changes are being made to provide clarification regarding measures for which 
better quality is associated with a lower score or numerator. Additional clarification is being 
provided regarding how the measure outcomes are included in the measure numerator and/or 
denominator for aggregate data. 
Description of Changes: 
Measure Outcomes (CMS Only) 
Change first paragraph for “D” to: 
D  In Measure Population (Used for Reporting): 
For rate-based measures: EOC record is a member of the measure’s population and 
the intent of the measure was not met. Note: For measures for which better quality is 
associated with a lower score or numerator, i.e., VTE-6 and PC-01, a measure 
outcome of “D” means that the appropriate care was provided and the intent of the 
measure was met. For aggregate data, the EOC record will be included in the 
measure denominator only.  
 
Change first paragraph for “E” to: 
E  In Numerator Population: 
For rate-based measures: EOC record is a member of the measure’s population and 
the intent of the measure was met. Note: For measures for which better quality is 
associated with a lower score or numerator, i.e., VTE-6 and PC-01, a measure 
outcome of “E” means that the appropriate care was not provided and the intent of the 
measure was not met.  For aggregate data, the EOC record will be included in both 
the measure numerator and denominator. 
 
Appendix F – Measure Name Crosswalk 
No updates in this section. 
 
Appendix G – Resources 
Impacts:   
N/A 
Rationale:  This change identifies the resources available on the voluntary electronic 
submission of the eMeasures for the Hospital Inpatient Quality Reporting Program.   
Description of Changes: 
CMS Hospital Inpatient Quality Reporting Program 
Add second paragraph: 
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For information on voluntary electronic submission of the Hospital IQR Program specified 
measures requirements and technical specifications, resources are available at 
http://www.qualitynet.org/. From the QualityNet web site select “Electronically Specified Clinical 
Quality Measures (eCQM) Reporting” located under Hospitals-Inpatient. If you have questions 
regarding the EHR Incentive Program measures collected for the Hospital IQR Program, 
please refer to the CMS website, http://www.cms.gov/Regulations-and-
Guidance/Legislation/EHRIncentivePrograms/Stage_2.html or the QualityNet helpdesk. 
 
Appendix H – Miscellaneous Tables 
Impacts:   
Index 
Rationale:  An additional table is being added to assist abstractors with data collection. 
Description of Changes: 
Change in row for Table 2.7 under ‘Name column’ from ‘Reserved for Future Use’ to: 
Anticoagulation Therapy Table 
 
Change under Page column to: 
Appendix H-6 
 
Add new table: 
Table 2.7 Anticoagulation Therapy Table 
 
Impacts:  
Table 2.3 VTE Parenteral Therapy Table 
Rationale:  This change is being made to assist abstractors with data collection. 
Description of Changes: 
Change first column header title to: 
VTE Parenteral Therapy 
  
Remove under “Direct Thrombin Inhibitors”: 
- argatroban  
- bivalirudin 
- lepirudin 
 
Add in “Inclusion/Synonyms” column for “Direct Thrombin Inhibitors” row: 
Acova 
Angiomax   
Angiox  
Recombinant Hirudin 
 
Appendix P – Preview Section 
Impacts:   
N/A 
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Rationale: The ICD-9 tables are being replaced with ICD-10 tables in the manual. 
Description of Changes: 
ICD-10 Code Tables 
Change to: 
The ICD-9 to ICD-10 crosswalks corresponding to the ICD-10 code tables in this appendix can 
be found on QualityNet.org via the following link:   
https://www.qualitynet.org/dcs/ContentServer?c=Page&pagename=QnetPublic%2FPage%2F
QnetTier3&cid=1228773919011 
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